Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19

Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease show hyperactivation of the immune system, which can affect multiple organs besides the lungs. Here, we propose that SARS-CoV...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nature reviews. Immunology Ročník 21; číslo 5; s. 319 - 329
Hlavní autoři: Bonaventura, Aldo, Vecchié, Alessandra, Dagna, Lorenzo, Martinod, Kimberly, Dixon, Dave L., Van Tassell, Benjamin W., Dentali, Francesco, Montecucco, Fabrizio, Massberg, Steffen, Levi, Marcel, Abbate, Antonio
Médium: Journal Article
Jazyk:angličtina
Vydáno: London Nature Publishing Group UK 01.05.2021
Nature Publishing Group
Témata:
ISSN:1474-1733, 1474-1741, 1474-1741
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease show hyperactivation of the immune system, which can affect multiple organs besides the lungs. Here, we propose that SARS-CoV-2 infection induces a process known as immunothrombosis, in which activated neutrophils and monocytes interact with platelets and the coagulation cascade, leading to intravascular clot formation in small and larger vessels. Microthrombotic complications may contribute to acute respiratory distress syndrome (ARDS) and other organ dysfunctions. Therapeutic strategies aimed at reducing immunothrombosis may therefore be useful. Several antithrombotic and immunomodulating drugs have been proposed as candidates to treat patients with SARS-CoV-2 infection. The growing understanding of SARS-CoV-2 infection pathogenesis and how it contributes to critical illness and its complications may help to improve risk stratification and develop targeted therapies to reduce the acute and long-term consequences of this disease. Here, the authors propose that SARS-CoV-2 induces a prothrombotic state, with dysregulated immunothrombosis in lung microvessels and endothelial injury, which drive the clinical manifestations of severe COVID-19. They discuss potential antithrombotic and immunomodulating drugs that are being considered in the treatment of patients with COVID-19.
AbstractList Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease show hyperactivation of the immune system, which can affect multiple organs besides the lungs. Here, we propose that SARS-CoV-2 infection induces a process known as immunothrombosis, in which activated neutrophils and monocytes interact with platelets and the coagulation cascade, leading to intravascular clot formation in small and larger vessels. Microthrombotic complications may contribute to acute respiratory distress syndrome (ARDS) and other organ dysfunctions. Therapeutic strategies aimed at reducing immunothrombosis may therefore be useful. Several antithrombotic and immunomodulating drugs have been proposed as candidates to treat patients with SARS-CoV-2 infection. The growing understanding of SARS-CoV-2 infection pathogenesis and how it contributes to critical illness and its complications may help to improve risk stratification and develop targeted therapies to reduce the acute and long-term consequences of this disease.
Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease show hyperactivation of the immune system, which can affect multiple organs besides the lungs. Here, we propose that SARS-CoV-2 infection induces a process known as immunothrombosis, in which activated neutrophils and monocytes interact with platelets and the coagulation cascade, leading to intravascular clot formation in small and larger vessels. Microthrombotic complications may contribute to acute respiratory distress syndrome (ARDS) and other organ dysfunctions. Therapeutic strategies aimed at reducing immunothrombosis may therefore be useful. Several antithrombotic and immunomodulating drugs have been proposed as candidates to treat patients with SARS-CoV-2 infection. The growing understanding of SARS-CoV-2 infection pathogenesis and how it contributes to critical illness and its complications may help to improve risk stratification and develop targeted therapies to reduce the acute and long-term consequences of this disease.Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease show hyperactivation of the immune system, which can affect multiple organs besides the lungs. Here, we propose that SARS-CoV-2 infection induces a process known as immunothrombosis, in which activated neutrophils and monocytes interact with platelets and the coagulation cascade, leading to intravascular clot formation in small and larger vessels. Microthrombotic complications may contribute to acute respiratory distress syndrome (ARDS) and other organ dysfunctions. Therapeutic strategies aimed at reducing immunothrombosis may therefore be useful. Several antithrombotic and immunomodulating drugs have been proposed as candidates to treat patients with SARS-CoV-2 infection. The growing understanding of SARS-CoV-2 infection pathogenesis and how it contributes to critical illness and its complications may help to improve risk stratification and develop targeted therapies to reduce the acute and long-term consequences of this disease.
Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease show hyperactivation of the immune system, which can affect multiple organs besides the lungs. Here, we propose that SARS-CoV-2 infection induces a process known as immunothrombosis, in which activated neutrophils and monocytes interact with platelets and the coagulation cascade, leading to intravascular clot formation in small and larger vessels. Microthrombotic complications may contribute to acute respiratory distress syndrome (ARDS) and other organ dysfunctions. Therapeutic strategies aimed at reducing immunothrombosis may therefore be useful. Several antithrombotic and immunomodulating drugs have been proposed as candidates to treat patients with SARS-CoV-2 infection. The growing understanding of SARS-CoV-2 infection pathogenesis and how it contributes to critical illness and its complications may help to improve risk stratification and develop targeted therapies to reduce the acute and long-term consequences of this disease.Here, the authors propose that SARS-CoV-2 induces a prothrombotic state, with dysregulated immunothrombosis in lung microvessels and endothelial injury, which drive the clinical manifestations of severe COVID-19. They discuss potential antithrombotic and immunomodulating drugs that are being considered in the treatment of patients with COVID-19.
Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with severe disease show hyperactivation of the immune system, which can affect multiple organs besides the lungs. Here, we propose that SARS-CoV-2 infection induces a process known as immunothrombosis, in which activated neutrophils and monocytes interact with platelets and the coagulation cascade, leading to intravascular clot formation in small and larger vessels. Microthrombotic complications may contribute to acute respiratory distress syndrome (ARDS) and other organ dysfunctions. Therapeutic strategies aimed at reducing immunothrombosis may therefore be useful. Several antithrombotic and immunomodulating drugs have been proposed as candidates to treat patients with SARS-CoV-2 infection. The growing understanding of SARS-CoV-2 infection pathogenesis and how it contributes to critical illness and its complications may help to improve risk stratification and develop targeted therapies to reduce the acute and long-term consequences of this disease. Here, the authors propose that SARS-CoV-2 induces a prothrombotic state, with dysregulated immunothrombosis in lung microvessels and endothelial injury, which drive the clinical manifestations of severe COVID-19. They discuss potential antithrombotic and immunomodulating drugs that are being considered in the treatment of patients with COVID-19.
Audience Academic
Author Van Tassell, Benjamin W.
Dentali, Francesco
Levi, Marcel
Montecucco, Fabrizio
Vecchié, Alessandra
Dixon, Dave L.
Martinod, Kimberly
Bonaventura, Aldo
Massberg, Steffen
Abbate, Antonio
Dagna, Lorenzo
Author_xml – sequence: 1
  givenname: Aldo
  orcidid: 0000-0002-4747-5535
  surname: Bonaventura
  fullname: Bonaventura, Aldo
  email: aldo.bonaventura@asst-settelaghi.it
  organization: Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa, Department of Internal Medicine, ASST dei Sette Laghi
– sequence: 2
  givenname: Alessandra
  surname: Vecchié
  fullname: Vecchié, Alessandra
  organization: Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Department of Internal Medicine, ASST dei Sette Laghi
– sequence: 3
  givenname: Lorenzo
  surname: Dagna
  fullname: Dagna, Lorenzo
  organization: Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University
– sequence: 4
  givenname: Kimberly
  orcidid: 0000-0002-1026-6107
  surname: Martinod
  fullname: Martinod, Kimberly
  organization: Center for Molecular and Vascular Biology, Department of Cardiovascular Sciences, KU Leuven
– sequence: 5
  givenname: Dave L.
  surname: Dixon
  fullname: Dixon, Dave L.
  organization: Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Department of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University
– sequence: 6
  givenname: Benjamin W.
  surname: Van Tassell
  fullname: Van Tassell, Benjamin W.
  organization: Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Department of Pharmacotherapy and Outcome Science, School of Pharmacy, Virginia Commonwealth University
– sequence: 7
  givenname: Francesco
  surname: Dentali
  fullname: Dentali, Francesco
  organization: Department of Medicine and Surgery, Insubria University
– sequence: 8
  givenname: Fabrizio
  orcidid: 0000-0003-0823-8729
  surname: Montecucco
  fullname: Montecucco, Fabrizio
  organization: IRCCS Ospedale Policlinico San Martino Genova — Italian Cardiovascular Network, First Clinic of Internal Medicine, Department of Internal Medicine and Centre of Excellence for Biomedical Research (CEBR), University of Genoa
– sequence: 9
  givenname: Steffen
  orcidid: 0000-0001-7387-3986
  surname: Massberg
  fullname: Massberg, Steffen
  organization: Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) e.V., Partner Site Munich Heart Alliance, Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig-Maximilians-Universität
– sequence: 10
  givenname: Marcel
  surname: Levi
  fullname: Levi, Marcel
  organization: Department of Medicine and Cardio-metabolic Programme — NIHR UCLH/UCL BRC, University College London Hospitals NHS Foundation Trust
– sequence: 11
  givenname: Antonio
  surname: Abbate
  fullname: Abbate, Antonio
  organization: Pauley Heart Center, Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33824483$$D View this record in MEDLINE/PubMed
BookMark eNp9kl2L1DAYhYOsuLujf8ALKQiiF13zNWl6IyzjqgMLC-p6G9I0abOmydik4vx7U2e_ZpGlFy19n3OSnJxjcOCD1wC8RPAEQcLfR4qWVVVCjEoIl4SV9RNwhGhFS1RRdHD7TcghOI7xCkLE8uQZOCSEY0o5OQKXZ74NqdfOSle022gmr5INvpC-LewwTD5PxzA0IdpYyFj81NtiI1MfOu2tKgateultHGJhfbG6-LH-WKL6OXhqpIv6xfV7AS4_nX1ffSnPLz6vV6fnpWIVTmVFKaRNQxHHpmlrCVXNG1xJ3CKkMWsUbgxhlCNiai2V4dxQI1te15TptqZkAT7sfDdTM-hWaZ9G6cRmtIMctyJIK_Yn3vaiC78Fh5gQWmeDt9cGY_g16ZjEYKPSzkmvwxQFXsKawSXjM_r6AXoVptHn42UKo7xJTNgd1UmnhfUm5HXVbCpOGYP52CjnvgAn_6Hy0-rBqnzLxub_e4J3e4LMJP0ndXKKUay_fd1n39xjey1d6mNw03ytcR98dT-929hu2pEBvgPUGGIctRHKJjn75O1aJxAUcxHFrogiF1H8K6KY08IPpDfuj4rIThQz7Ds93kX8iOovTfPtJA
CitedBy_id crossref_primary_10_12998_wjcc_v12_i9_1704
crossref_primary_10_3390_cancers13194750
crossref_primary_10_1007_s11427_023_2624_9
crossref_primary_10_1016_j_cnc_2021_08_003
crossref_primary_10_1016_j_xops_2024_100638
crossref_primary_10_1007_s00134_022_06794_y
crossref_primary_10_1016_j_cmi_2022_11_008
crossref_primary_10_1161_STROKEAHA_121_038056
crossref_primary_10_1590_0074_02760220239
crossref_primary_10_1097_FJC_0000000000001522
crossref_primary_10_1186_s12931_022_01944_8
crossref_primary_10_3390_life13030712
crossref_primary_10_1016_j_csbj_2022_08_011
crossref_primary_10_1016_j_jdiacomp_2025_109151
crossref_primary_10_1136_rmdopen_2025_005469
crossref_primary_10_1016_j_biopha_2022_113568
crossref_primary_10_1177_00368504251366362
crossref_primary_10_1183_23120541_00863_2024
crossref_primary_10_1186_s12959_025_00706_y
crossref_primary_10_1016_j_virusres_2024_199393
crossref_primary_10_1016_j_annepidem_2025_08_015
crossref_primary_10_3389_fimmu_2021_658896
crossref_primary_10_1016_j_thromres_2021_11_027
crossref_primary_10_1186_s12872_025_04472_7
crossref_primary_10_1038_s41577_022_00734_z
crossref_primary_10_3389_fimmu_2022_999534
crossref_primary_10_1016_j_bcp_2022_114909
crossref_primary_10_1016_j_intimp_2024_111788
crossref_primary_10_1007_s43440_022_00438_0
crossref_primary_10_1002_mco2_70344
crossref_primary_10_1055_s_0044_1790603
crossref_primary_10_23946_2500_0764_2022_7_4_45_50
crossref_primary_10_1007_s00063_022_00919_3
crossref_primary_10_3390_pathogens11080867
crossref_primary_10_1186_s13063_023_07616_2
crossref_primary_10_1186_s12959_023_00504_4
crossref_primary_10_3390_ijerph19074262
crossref_primary_10_1016_j_imlet_2023_01_010
crossref_primary_10_1002_jcla_24941
crossref_primary_10_1097_TP_0000000000004606
crossref_primary_10_1038_s41598_024_51908_9
crossref_primary_10_1007_s11739_023_03383_9
crossref_primary_10_1177_03009858211057197
crossref_primary_10_3390_cells11060922
crossref_primary_10_1016_j_ijid_2022_09_005
crossref_primary_10_3389_fimmu_2022_978977
crossref_primary_10_1177_08850666211051960
crossref_primary_10_1016_j_hermed_2024_100923
crossref_primary_10_7759_cureus_37275
crossref_primary_10_1007_s00234_024_03411_1
crossref_primary_10_1136_ard_2023_224092
crossref_primary_10_3390_v15030706
crossref_primary_10_3390_vaccines10111966
crossref_primary_10_1016_j_compbiomed_2022_105601
crossref_primary_10_1016_S2665_9913_21_00316_7
crossref_primary_10_3389_fphar_2022_1079511
crossref_primary_10_1016_j_jri_2024_104207
crossref_primary_10_3390_antibiotics11091166
crossref_primary_10_3389_fcvm_2021_802566
crossref_primary_10_1186_s40001_024_01720_y
crossref_primary_10_3390_cells12050778
crossref_primary_10_3390_jcm12113727
crossref_primary_10_3390_ijms231810372
crossref_primary_10_1002_adhm_202402103
crossref_primary_10_3390_ijms24031920
crossref_primary_10_1016_j_ijid_2021_08_058
crossref_primary_10_1159_000533286
crossref_primary_10_3389_fimmu_2025_1593885
crossref_primary_10_1093_eurheartj_ehaf222
crossref_primary_10_3390_vaccines11020435
crossref_primary_10_1515_hsz_2021_0245
crossref_primary_10_3389_fneur_2022_984135
crossref_primary_10_1016_j_immuni_2025_03_020
crossref_primary_10_3389_fmed_2023_1212201
crossref_primary_10_37219_2528_8253_2024_2_14
crossref_primary_10_1111_hae_14877
crossref_primary_10_3390_biomedicines12030636
crossref_primary_10_1016_j_ijid_2022_02_019
crossref_primary_10_3889_oamjms_2022_7958
crossref_primary_10_3389_fphys_2023_1113968
crossref_primary_10_3389_fimmu_2024_1452788
crossref_primary_10_1002_jbt_23605
crossref_primary_10_1007_s11010_023_04658_7
crossref_primary_10_1097_MS9_0000000000000555
crossref_primary_10_1002_pro_4451
crossref_primary_10_1038_s41392_021_00690_5
crossref_primary_10_1038_s41467_021_27325_1
crossref_primary_10_1007_s00405_022_07620_3
crossref_primary_10_1007_s00277_023_05234_1
crossref_primary_10_3389_fcimb_2022_844000
crossref_primary_10_3390_hematolrep14040050
crossref_primary_10_1136_bmjopen_2024_084311
crossref_primary_10_1007_s11239_021_02617_x
crossref_primary_10_1113_EP090802
crossref_primary_10_3389_fimmu_2021_716940
crossref_primary_10_3389_fimmu_2021_778913
crossref_primary_10_1001_jamapediatrics_2023_6022
crossref_primary_10_1055_a_1646_3392
crossref_primary_10_3390_biomedicines9070781
crossref_primary_10_31083_j_fbl2803059
crossref_primary_10_5662_wjm_v12_i5_331
crossref_primary_10_1212_NXI_0000000000200227
crossref_primary_10_3389_fonc_2022_1000215
crossref_primary_10_3390_covid5060089
crossref_primary_10_3390_jcm11040948
crossref_primary_10_1016_j_prostaglandins_2022_106619
crossref_primary_10_1016_j_ceb_2023_102287
crossref_primary_10_1182_blood_2023021166
crossref_primary_10_1007_s12149_024_01970_0
crossref_primary_10_1016_j_yjmcc_2024_05_005
crossref_primary_10_1186_s12985_023_02116_w
crossref_primary_10_1007_s12192_023_01379_0
crossref_primary_10_3390_jcm12186067
crossref_primary_10_1007_s13659_024_00432_4
crossref_primary_10_3390_ijms241914876
crossref_primary_10_1007_s11739_021_02865_y
crossref_primary_10_3389_fimmu_2022_1042751
crossref_primary_10_3390_cells13110892
crossref_primary_10_1183_13993003_00377_2021
crossref_primary_10_1007_s13577_022_00785_3
crossref_primary_10_1080_09286586_2024_2399345
crossref_primary_10_1111_aas_14072
crossref_primary_10_1016_j_ejim_2021_04_019
crossref_primary_10_1080_17474086_2022_2052040
crossref_primary_10_3390_ijms26104582
crossref_primary_10_1111_jth_15882
crossref_primary_10_3390_life15050707
crossref_primary_10_3390_jcm11164896
crossref_primary_10_1007_s40259_022_00529_7
crossref_primary_10_2174_0113892037324425241018061548
crossref_primary_10_3389_fimmu_2022_858256
crossref_primary_10_1161_ATVBAHA_122_318748
crossref_primary_10_3390_cancers16020450
crossref_primary_10_1016_j_rpth_2024_102344
crossref_primary_10_3390_ijms25053042
crossref_primary_10_1177_00033197241251905
crossref_primary_10_1016_j_intimp_2022_108805
crossref_primary_10_3389_fcvm_2021_824112
crossref_primary_10_1002_cam4_70795
crossref_primary_10_1186_s12959_024_00653_0
crossref_primary_10_3390_ijms26115102
crossref_primary_10_1186_s10020_022_00510_8
crossref_primary_10_3390_jcm11133822
crossref_primary_10_1098_rsob_230349
crossref_primary_10_3389_fcell_2025_1576067
crossref_primary_10_1007_s10096_024_04793_z
crossref_primary_10_3389_fcvm_2021_767074
crossref_primary_10_1002_eji_202451546
crossref_primary_10_1212_NXI_0000000000200127
crossref_primary_10_1016_j_isci_2024_110344
crossref_primary_10_1016_j_jaut_2022_102868
crossref_primary_10_3389_fimmu_2025_1594891
crossref_primary_10_1007_s12026_023_09371_7
crossref_primary_10_1016_j_rpth_2024_102339
crossref_primary_10_1111_and_14219
crossref_primary_10_1007_s11739_022_02981_3
crossref_primary_10_1007_s11684_023_1044_4
crossref_primary_10_1186_s12879_024_09373_2
crossref_primary_10_3390_medicina61050933
crossref_primary_10_1124_pharmrev_122_000684
crossref_primary_10_1186_s40168_022_01260_9
crossref_primary_10_1186_s41100_021_00378_0
crossref_primary_10_1016_j_jaip_2024_05_025
crossref_primary_10_1016_j_medj_2021_06_009
crossref_primary_10_1038_s44161_023_00414_8
crossref_primary_10_1134_S1019331622040062
crossref_primary_10_1183_23120541_00317_2022
crossref_primary_10_3389_fnano_2022_987117
crossref_primary_10_1002_eji_202250010
crossref_primary_10_3390_v13091855
crossref_primary_10_1177_2632010X241304958
crossref_primary_10_3389_fimmu_2021_770436
crossref_primary_10_3389_fmed_2022_929408
crossref_primary_10_1136_bmjopen_2021_053684
crossref_primary_10_1002_mco2_94
crossref_primary_10_1002_jmv_29556
crossref_primary_10_3390_jcdd8100130
crossref_primary_10_1055_s_0042_1757163
crossref_primary_10_3389_fcell_2025_1476329
crossref_primary_10_3389_fimmu_2025_1623309
crossref_primary_10_1038_s41467_022_28639_4
crossref_primary_10_1007_s15010_022_01835_6
crossref_primary_10_3389_fimmu_2022_844701
crossref_primary_10_3390_ijms23073711
crossref_primary_10_1007_s00011_022_01615_w
crossref_primary_10_3390_jcm10122558
crossref_primary_10_1177_19714009241240312
crossref_primary_10_3389_fimmu_2022_838011
crossref_primary_10_3390_foods12101937
crossref_primary_10_1016_j_crmeth_2025_101022
crossref_primary_10_3389_fimmu_2025_1624770
crossref_primary_10_3389_fmed_2023_1271863
crossref_primary_10_3389_fphar_2021_708665
crossref_primary_10_12998_wjcc_v10_i23_8088
crossref_primary_10_1128_mbio_00189_25
crossref_primary_10_3390_children11030295
crossref_primary_10_3390_medicina60091489
crossref_primary_10_4103_1673_5374_389625
crossref_primary_10_1128_spectrum_04168_23
crossref_primary_10_1016_j_heliyon_2024_e27290
crossref_primary_10_1111_bcpt_13650
crossref_primary_10_1007_s10072_023_06682_3
crossref_primary_10_1038_s41420_024_01844_4
crossref_primary_10_1038_s41598_022_08853_2
crossref_primary_10_1016_j_semcdb_2023_05_001
crossref_primary_10_1002_adbi_202200265
crossref_primary_10_1136_heartjnl_2022_320845
crossref_primary_10_3390_pharmaceutics15051562
crossref_primary_10_1007_s11239_024_03028_4
crossref_primary_10_1038_s41467_023_36333_2
crossref_primary_10_1186_s13104_024_06875_9
crossref_primary_10_3390_jcm11051452
crossref_primary_10_3390_genes14030617
crossref_primary_10_1177_10668969241236704
crossref_primary_10_3390_v14071403
crossref_primary_10_1089_met_2023_0083
crossref_primary_10_1002_jmv_27158
crossref_primary_10_3390_cancers14194581
crossref_primary_10_3389_fcvm_2023_1094786
crossref_primary_10_2478_aite_2024_0021
crossref_primary_10_1177_00033197231153204
crossref_primary_10_1016_j_intimp_2025_114934
crossref_primary_10_1016_j_jcrc_2022_154010
crossref_primary_10_3390_ijms222413480
crossref_primary_10_1038_s41418_023_01124_1
crossref_primary_10_3390_life14030315
crossref_primary_10_1111_all_14953
crossref_primary_10_12688_f1000research_54193_2
crossref_primary_10_1186_s12931_022_02278_1
crossref_primary_10_12688_f1000research_54193_1
crossref_primary_10_1097_CCE_0000000000001128
crossref_primary_10_3389_fimmu_2022_897487
crossref_primary_10_7189_jogh_14_05001
crossref_primary_10_1016_j_atssr_2023_12_019
crossref_primary_10_1016_j_thromres_2022_02_016
crossref_primary_10_24287_1726_1708_2024_23_1_211_218
crossref_primary_10_3389_fmed_2023_1222767
crossref_primary_10_1016_j_pharmthera_2025_108904
crossref_primary_10_1016_j_jocn_2023_09_028
crossref_primary_10_1038_s41598_024_59385_w
crossref_primary_10_3389_fmed_2021_817305
crossref_primary_10_3390_diagnostics13061069
crossref_primary_10_2147_JIR_S413892
crossref_primary_10_1016_j_jahd_2024_100012
crossref_primary_10_3389_fimmu_2021_738697
crossref_primary_10_1038_s41392_023_01669_0
crossref_primary_10_1186_s12879_022_07520_1
crossref_primary_10_1210_endrev_bnad032
crossref_primary_10_1016_j_ejim_2022_04_009
crossref_primary_10_1038_s41392_025_02178_y
crossref_primary_10_3390_v16010121
crossref_primary_10_1007_s11239_024_02975_2
crossref_primary_10_1016_j_jtha_2023_04_039
crossref_primary_10_3390_antiox12020326
crossref_primary_10_1186_s12959_025_00749_1
crossref_primary_10_1016_j_biomaterials_2024_122889
crossref_primary_10_3389_fimmu_2021_732913
crossref_primary_10_1007_s10753_024_02136_w
crossref_primary_10_1016_j_jjcc_2022_08_011
crossref_primary_10_3389_fimmu_2022_861251
crossref_primary_10_3389_fimmu_2023_1116131
crossref_primary_10_1016_j_ebiom_2022_104305
crossref_primary_10_1111_myc_13679
crossref_primary_10_1016_j_clim_2023_109240
crossref_primary_10_1080_10715762_2025_2529914
crossref_primary_10_1177_10760296221135792
crossref_primary_10_1186_s13054_021_03846_5
crossref_primary_10_1016_j_intimp_2022_108615
crossref_primary_10_1111_bcpt_13690
crossref_primary_10_3390_md22060283
crossref_primary_10_1007_s00259_021_05619_2
crossref_primary_10_1186_s13613_023_01130_z
crossref_primary_10_1161_CIRCRESAHA_122_321877
crossref_primary_10_1093_cvr_cvad084
crossref_primary_10_1016_j_jcrc_2023_154463
crossref_primary_10_1007_s13167_022_00293_2
crossref_primary_10_1183_23120541_00006_2024
crossref_primary_10_1182_bloodadvances_2022007444
crossref_primary_10_1038_s41467_023_40824_7
crossref_primary_10_1093_infdis_jiaf415
crossref_primary_10_1016_j_biopha_2022_113704
crossref_primary_10_1016_j_vph_2022_106975
crossref_primary_10_3389_fimmu_2022_827146
crossref_primary_10_3389_fimmu_2022_851497
crossref_primary_10_1016_j_jss_2025_02_001
crossref_primary_10_1038_s41586_023_06287_y
crossref_primary_10_1055_s_0042_1757183
crossref_primary_10_3390_biom15071004
crossref_primary_10_1007_s00210_022_02346_9
crossref_primary_10_3389_fendo_2023_1073878
crossref_primary_10_3390_ijms242316886
crossref_primary_10_1007_s11239_025_03144_9
crossref_primary_10_3390_biomedicines12091982
crossref_primary_10_1007_s00011_023_01823_y
crossref_primary_10_3390_v15081748
crossref_primary_10_3390_jcm10122535
crossref_primary_10_3389_fimmu_2023_1129766
crossref_primary_10_3233_CH_221401
crossref_primary_10_3390_neurolint15030056
crossref_primary_10_1055_a_1962_5447
crossref_primary_10_1055_a_2619_2485
crossref_primary_10_1136_bmjresp_2024_002323
crossref_primary_10_1182_blood_2022016089
crossref_primary_10_1007_s12020_024_03758_8
crossref_primary_10_1177_21501319241254751
crossref_primary_10_1080_20477724_2021_2024030
crossref_primary_10_1038_s41440_022_01145_2
crossref_primary_10_3390_ijms22157942
crossref_primary_10_3389_fmed_2025_1530411
crossref_primary_10_3390_jcm11061564
crossref_primary_10_3389_fmed_2022_941422
crossref_primary_10_3390_ijms23073868
crossref_primary_10_1038_s41423_024_01174_6
crossref_primary_10_1186_s12872_024_04066_9
crossref_primary_10_3390_jcm10184190
crossref_primary_10_3390_ijms222413638
crossref_primary_10_1016_j_beha_2022_101402
crossref_primary_10_1002_cbdv_202403202
crossref_primary_10_3389_fimmu_2025_1599639
crossref_primary_10_1182_bloodadvances_2022007143
crossref_primary_10_1111_joim_13585
crossref_primary_10_3390_v13112128
crossref_primary_10_1002_jca_22147
crossref_primary_10_1016_j_labinv_2023_100179
crossref_primary_10_3389_fimmu_2022_957224
crossref_primary_10_1080_09553002_2023_2295298
crossref_primary_10_1016_j_preteyeres_2024_101285
crossref_primary_10_1161_ATVBAHA_122_317162
crossref_primary_10_3748_wjg_v28_i42_6017
crossref_primary_10_1080_17476348_2023_2210837
crossref_primary_10_1016_j_htct_2025_103963
crossref_primary_10_1016_j_heliyon_2024_e30760
crossref_primary_10_1002_pul2_12191
crossref_primary_10_1016_j_jtha_2024_11_028
crossref_primary_10_3390_diagnostics13050920
crossref_primary_10_1038_s41583_023_00769_8
crossref_primary_10_1038_s41598_023_30305_8
crossref_primary_10_1016_j_thromres_2022_08_017
crossref_primary_10_3389_fcimb_2023_1320933
crossref_primary_10_1186_s12929_022_00833_y
crossref_primary_10_1038_s41467_021_27649_y
crossref_primary_10_1111_febs_16808
crossref_primary_10_3390_ijms24087278
crossref_primary_10_3390_ijms232315126
crossref_primary_10_1097_SHK_0000000000002291
crossref_primary_10_1089_dna_2021_1101
crossref_primary_10_1016_j_smim_2022_101644
crossref_primary_10_1038_s41379_021_00915_6
crossref_primary_10_1186_s40001_023_01301_5
crossref_primary_10_1016_j_thromres_2024_109195
crossref_primary_10_3892_br_2023_1647
crossref_primary_10_1007_s12020_023_03439_y
crossref_primary_10_1016_j_rpth_2023_100282
crossref_primary_10_3233_CH_221554
crossref_primary_10_1016_j_actbio_2024_01_046
crossref_primary_10_3390_jcm13175094
crossref_primary_10_1016_j_jconrel_2023_05_018
crossref_primary_10_1182_bloodadvances_2023012367
crossref_primary_10_3390_biomedicines10092258
crossref_primary_10_1042_BCJ20220154
crossref_primary_10_1016_j_rpth_2023_100041
crossref_primary_10_1002_adma_202304903
crossref_primary_10_1007_s00011_022_01540_y
crossref_primary_10_1016_j_cytogfr_2021_10_007
crossref_primary_10_1002_eji_70001
crossref_primary_10_1007_s12519_023_00790_y
crossref_primary_10_1002_jcu_23160
crossref_primary_10_1007_s12185_022_03308_w
crossref_primary_10_1186_s12931_025_03331_5
crossref_primary_10_1161_ATVBAHA_121_316930
crossref_primary_10_3390_jpm13091351
crossref_primary_10_1183_16000617_0153_2024
crossref_primary_10_1371_journal_pone_0296030
crossref_primary_10_3390_ph14080751
crossref_primary_10_1016_j_ejim_2025_106448
crossref_primary_10_3389_fimmu_2022_776861
crossref_primary_10_1002_smll_202311165
crossref_primary_10_1038_s41577_023_00834_4
crossref_primary_10_1182_bloodadvances_2022009430
crossref_primary_10_3390_biomedicines10092242
crossref_primary_10_1177_10815589241288515
crossref_primary_10_1186_s12931_024_02908_w
crossref_primary_10_3390_ijms25010047
crossref_primary_10_3390_ijms23116022
crossref_primary_10_1093_ofid_ofab588
crossref_primary_10_3390_ijms26189217
crossref_primary_10_1016_j_gastha_2023_10_006
crossref_primary_10_1016_j_jtha_2023_02_033
crossref_primary_10_1097_MD_0000000000039566
crossref_primary_10_3389_fimmu_2022_1039618
crossref_primary_10_3390_ijms26178211
crossref_primary_10_1016_j_thromres_2024_05_002
crossref_primary_10_1161_CIRCRESAHA_122_321541
crossref_primary_10_3233_JRS_210064
crossref_primary_10_1016_j_ejim_2023_05_032
crossref_primary_10_3389_fcvm_2022_1013262
crossref_primary_10_3389_fimmu_2022_830061
crossref_primary_10_1186_s12883_025_04212_6
crossref_primary_10_1007_s11033_021_06770_7
crossref_primary_10_1186_s13287_025_04472_6
crossref_primary_10_1007_s00508_022_02018_x
crossref_primary_10_3389_fcimb_2024_1425547
crossref_primary_10_3389_fneur_2025_1513124
crossref_primary_10_1097_MOH_0000000000000724
crossref_primary_10_3390_vaccines11030510
crossref_primary_10_1055_s_0044_1790259
crossref_primary_10_1016_j_bcmd_2023_102782
crossref_primary_10_1186_s12890_023_02313_x
crossref_primary_10_3389_fimmu_2024_1457324
crossref_primary_10_1016_j_jtha_2024_12_021
crossref_primary_10_1071_MA24007
crossref_primary_10_1007_s40618_021_01718_x
crossref_primary_10_1093_brain_awad008
crossref_primary_10_1007_s11739_021_02800_1
crossref_primary_10_3389_fimmu_2024_1281263
crossref_primary_10_3389_fimmu_2024_1493306
crossref_primary_10_1007_s10875_022_01386_3
crossref_primary_10_1016_j_jtha_2023_09_014
crossref_primary_10_1161_ATVBAHA_122_318179
crossref_primary_10_1038_s41569_021_00665_7
crossref_primary_10_1002_JLB_3MIR0221_100R
crossref_primary_10_1371_journal_ppat_1011063
crossref_primary_10_1016_j_jtha_2023_09_022
crossref_primary_10_1002_jmv_28678
crossref_primary_10_1002_jmv_29887
crossref_primary_10_1016_j_mvr_2022_104361
crossref_primary_10_1097_MJT_0000000000001515
crossref_primary_10_1001_jamanetworkopen_2021_40568
crossref_primary_10_1002_rth2_12718
crossref_primary_10_1111_imm_13564
crossref_primary_10_3390_diagnostics11060995
crossref_primary_10_1016_j_cjca_2023_07_002
crossref_primary_10_1097_CCE_0000000000000692
crossref_primary_10_3390_covid5090156
crossref_primary_10_21518_ms2025_039
crossref_primary_10_1002_prp2_988
crossref_primary_10_1016_j_cellimm_2022_104562
crossref_primary_10_3390_biomedicines12071618
crossref_primary_10_1016_j_trsl_2021_11_005
crossref_primary_10_1161_CIRCRESAHA_123_321876
crossref_primary_10_3389_fcell_2021_792335
crossref_primary_10_1007_s00726_025_03453_6
crossref_primary_10_1097_MCP_0000000000000834
crossref_primary_10_3389_fcell_2022_824851
crossref_primary_10_3389_fcimb_2023_1268016
crossref_primary_10_3390_jcm11237161
crossref_primary_10_1038_s41401_024_01295_8
crossref_primary_10_3389_fgene_2022_889348
crossref_primary_10_3390_ijms24032492
crossref_primary_10_1111_imr_13179
crossref_primary_10_3389_fimmu_2021_664209
crossref_primary_10_3390_diagnostics12112792
crossref_primary_10_1111_imr_13175
crossref_primary_10_1161_CIRCRESAHA_123_321750
crossref_primary_10_3390_biomedicines12040913
crossref_primary_10_1007_s10787_023_01239_4
crossref_primary_10_1055_s_0043_1768969
crossref_primary_10_1007_s00018_021_04096_y
crossref_primary_10_1186_s12872_024_04030_7
crossref_primary_10_1186_s12929_022_00832_z
crossref_primary_10_3389_fneur_2024_1344862
crossref_primary_10_3389_fimmu_2022_1046574
crossref_primary_10_3390_ijms252011267
crossref_primary_10_1016_j_jtha_2024_02_013
crossref_primary_10_1007_s10456_023_09878_5
crossref_primary_10_1055_a_1581_4355
crossref_primary_10_3390_antiox14070840
crossref_primary_10_1097_GH9_0000000000000409
crossref_primary_10_1016_j_ebiom_2022_104299
crossref_primary_10_1186_s40560_023_00665_4
crossref_primary_10_3389_fcvm_2024_1384996
crossref_primary_10_1016_j_jacadv_2023_100780
crossref_primary_10_1042_BCJ20210522
crossref_primary_10_1016_j_rpth_2022_100025
crossref_primary_10_1038_s41586_025_09076_x
crossref_primary_10_1016_j_amjms_2021_12_010
crossref_primary_10_2147_IDR_S491101
crossref_primary_10_1002_eji_202149410
crossref_primary_10_1038_s43856_023_00395_6
crossref_primary_10_1371_journal_pone_0317110
crossref_primary_10_3389_fimmu_2023_1168455
crossref_primary_10_1007_s10096_024_04755_5
crossref_primary_10_1016_j_heliyon_2023_e19605
crossref_primary_10_1016_j_yjmcc_2022_04_011
crossref_primary_10_1186_s13024_024_00754_4
crossref_primary_10_1113_JP284879
crossref_primary_10_3389_fimmu_2022_815833
crossref_primary_10_1055_a_1854_2693
crossref_primary_10_1016_j_ejim_2021_11_015
crossref_primary_10_1016_j_biopha_2023_114530
crossref_primary_10_3389_fcimb_2021_721309
crossref_primary_10_5501_wjv_v12_i2_68
crossref_primary_10_3389_fimmu_2023_1031336
crossref_primary_10_1038_s41590_021_00963_9
crossref_primary_10_1097_CCM_0000000000005467
crossref_primary_10_3390_jcm11174980
crossref_primary_10_1161_ATVBAHA_123_318801
crossref_primary_10_1038_s41385_021_00464_w
crossref_primary_10_3390_ijms24065739
crossref_primary_10_1016_j_ebiom_2022_104185
crossref_primary_10_3389_fimmu_2025_1567522
crossref_primary_10_1186_s12967_024_05044_7
crossref_primary_10_1111_bjh_19722
crossref_primary_10_1016_j_intimp_2023_111458
crossref_primary_10_3390_jcm10194373
crossref_primary_10_1097_CCE_0000000000000827
crossref_primary_10_1016_j_jtha_2022_12_002
crossref_primary_10_1111_bjh_17664
crossref_primary_10_3389_fimmu_2021_799558
crossref_primary_10_1016_j_jbc_2025_110455
crossref_primary_10_1016_j_stem_2023_09_001
crossref_primary_10_1038_s41598_025_17054_6
crossref_primary_10_1186_s12879_025_10684_1
crossref_primary_10_1080_02648725_2022_2147661
crossref_primary_10_1080_17476348_2022_2119131
crossref_primary_10_1007_s12264_023_01110_0
crossref_primary_10_1097_CCE_0000000000000945
crossref_primary_10_1002_iid3_798
crossref_primary_10_3390_ijms25010668
crossref_primary_10_1038_s41598_023_37390_9
crossref_primary_10_1681_ASN_0000000000000153
crossref_primary_10_1186_s41983_023_00772_x
crossref_primary_10_3390_diagnostics13111905
crossref_primary_10_1093_oxfimm_iqac006
crossref_primary_10_3390_v14122753
crossref_primary_10_3390_diagnostics11071271
crossref_primary_10_1038_s41591_021_01643_9
crossref_primary_10_1212_WNL_0000000000201265
crossref_primary_10_3390_v14030565
crossref_primary_10_1093_cid_ciab732
crossref_primary_10_3390_biomedicines11071790
crossref_primary_10_1186_s40560_023_00679_y
crossref_primary_10_3389_fonc_2024_1446482
crossref_primary_10_3389_fimmu_2025_1591860
crossref_primary_10_1016_j_jconrel_2025_114220
crossref_primary_10_3390_ijms232314532
crossref_primary_10_1007_s00392_024_02464_9
crossref_primary_10_1016_j_medcle_2024_10_002
crossref_primary_10_2217_fmb_2021_0252
crossref_primary_10_2217_fmb_2021_0250
crossref_primary_10_3390_jcm10245815
crossref_primary_10_1038_s42003_023_05287_y
crossref_primary_10_1016_j_ajpath_2021_09_004
crossref_primary_10_1165_rcmb_2022_0373OC
crossref_primary_10_3389_fphar_2022_742273
crossref_primary_10_1016_j_tcm_2021_08_012
crossref_primary_10_1016_S2213_2600_21_00221_6
crossref_primary_10_1039_D4LC00848K
crossref_primary_10_3390_microorganisms13081791
crossref_primary_10_3390_v15122301
crossref_primary_10_1038_s41467_022_34910_5
crossref_primary_10_3390_hematolrep15020024
crossref_primary_10_1038_s41467_022_32867_z
crossref_primary_10_1038_s41586_022_04421_w
crossref_primary_10_3390_jcm10173891
crossref_primary_10_1055_s_0041_1740182
crossref_primary_10_3390_jcm12041399
crossref_primary_10_1016_j_cell_2024_07_012
crossref_primary_10_3389_fphar_2023_1304697
crossref_primary_10_1038_s44161_022_00029_5
crossref_primary_10_1055_a_1562_7599
crossref_primary_10_1038_s41598_025_95122_7
crossref_primary_10_7717_peerj_12159
crossref_primary_10_1080_15548627_2022_2099206
crossref_primary_10_1016_j_jacc_2022_04_061
crossref_primary_10_1016_j_jacc_2022_04_060
crossref_primary_10_1038_s41598_023_48912_w
crossref_primary_10_1038_s41467_024_44986_w
crossref_primary_10_3390_jpm12101711
crossref_primary_10_1186_s13054_025_05283_0
crossref_primary_10_1111_jth_15806
crossref_primary_10_1038_s41467_023_39174_1
crossref_primary_10_1177_15353702221139185
crossref_primary_10_1134_S2079057024600046
crossref_primary_10_1097_CCE_0000000000000851
crossref_primary_10_4081_itjm_2024_1707
crossref_primary_10_1016_j_ijbiomac_2025_140639
crossref_primary_10_1186_s40635_023_00520_8
crossref_primary_10_3389_fphys_2023_1235172
crossref_primary_10_1186_s13613_023_01115_y
crossref_primary_10_1371_journal_pone_0262751
crossref_primary_10_3390_ijms241713194
crossref_primary_10_1038_s41577_022_00762_9
crossref_primary_10_3389_fimmu_2023_1227547
crossref_primary_10_1016_j_virusres_2021_198631
crossref_primary_10_3390_jcm11113024
crossref_primary_10_1002_mco2_70390
crossref_primary_10_1016_j_micpath_2024_106558
crossref_primary_10_3389_fimmu_2024_1394925
crossref_primary_10_3390_ijms25042342
crossref_primary_10_3390_ijms23137416
crossref_primary_10_1186_s13613_025_01483_7
crossref_primary_10_1038_s42003_023_04805_2
crossref_primary_10_1515_cclm_2022_0199
crossref_primary_10_3928_23258160_20250701_01
crossref_primary_10_1055_a_1661_0257
crossref_primary_10_1093_infdis_jiab601
crossref_primary_10_1016_j_lfs_2022_121018
crossref_primary_10_3389_fcell_2022_914891
crossref_primary_10_3390_immuno2010001
crossref_primary_10_1038_s41598_022_26473_8
crossref_primary_10_1016_j_ekir_2025_07_021
crossref_primary_10_3390_ijerph182412944
crossref_primary_10_1038_s41579_022_00713_0
crossref_primary_10_1007_s12020_024_04078_7
crossref_primary_10_1177_20417314241310541
crossref_primary_10_1097_CCE_0000000000000986
crossref_primary_10_1016_j_ebiom_2022_104195
crossref_primary_10_1007_s10072_023_07266_x
crossref_primary_10_3390_diagnostics15131650
crossref_primary_10_3389_fimmu_2023_1125960
crossref_primary_10_1016_j_intimp_2022_109040
crossref_primary_10_1371_journal_pone_0262783
crossref_primary_10_3389_fmicb_2021_819638
crossref_primary_10_1161_ATVBAHA_123_320185
crossref_primary_10_3390_diagnostics13223477
crossref_primary_10_3390_clinpract14030055
crossref_primary_10_3390_microorganisms13010144
crossref_primary_10_3390_biom12070971
crossref_primary_10_3748_wjg_v30_i22_2866
crossref_primary_10_1161_CIRCULATIONAHA_123_065619
crossref_primary_10_3390_biomedicines10061332
crossref_primary_10_3389_fimmu_2021_719023
crossref_primary_10_3390_v16101615
crossref_primary_10_1016_j_heliyon_2024_e30955
crossref_primary_10_1186_s43162_023_00195_3
crossref_primary_10_7759_cureus_66555
crossref_primary_10_1016_j_ccm_2022_11_009
crossref_primary_10_1016_j_thromres_2024_109135
crossref_primary_10_1371_journal_ppat_1010106
crossref_primary_10_3389_fimmu_2023_1133225
Cites_doi 10.1016/j.jinf.2020.11.041
10.1016/j.virusres.2007.01.022
10.1111/j.1538-7836.2011.04422.x
10.1172/jci.insight.140711
10.1001/jama.2020.12839
10.1016/j.apsb.2020.04.008
10.1016/j.clim.2020.108450
10.1056/NEJMcp2009575
10.1038/s41577-020-0343-0
10.1016/j.numecd.2020.07.040
10.1161/01.ATV.0000051384.43104.FC
10.1182/blood-2018-11-882993
10.1172/jci.insight.98178
10.1002/rth2.12400
10.1016/j.ebiom.2020.102833
10.1182/blood-2012-01-405183
10.1016/S0140-6736(20)30628-0
10.1038/s41586-020-2488-1
10.1007/s00134-020-06033-2
10.1038/s41577-020-0320-7
10.1111/joim.13091
10.1038/s41586-020-2196-x
10.1016/S2665-9913(20)30420-3
10.1038/s41423-018-0024-0
10.1007/s00281-017-0639-8
10.1016/j.nmni.2020.100756
10.7326/M20-2003
10.1016/S0140-6736(20)30937-5
10.1126/scitranslmed.abd3876
10.1016/j.cub.2005.12.039
10.3201/eid2609.201353
10.1038/s41591-020-0968-3
10.1128/mBio.00271-13
10.1038/nm.2184
10.1160/TH14-09-0731
10.4049/jimmunol.0802884
10.1016/j.jacc.2020.05.001
10.1038/nri2532
10.1084/jem.20201012
10.1016/S2666-5247(20)30144-0
10.1016/j.blre.2020.100731
10.1164/rccm.202003-0817LE
10.1111/jth.14817
10.1007/s00011-020-01401-6
10.1161/CIRCRESAHA.120.317447
10.1097/FJC.0000000000000893
10.1111/jth.14768
10.1111/jth.14872
10.1038/s41577-020-0311-8
10.1126/scitranslmed.3006804
10.1016/j.clim.2020.108598
10.1016/S2213-2600(20)30404-5
10.1016/j.jhep.2020.05.002
10.1097/01.CCM.0000133332.48386.85
10.4049/jimmunol.177.7.4794
10.1007/s11926-018-0773-x
10.1016/S2213-2600(20)30076-X
10.1016/S2352-3026(20)30109-5
10.1016/j.thromres.2020.07.034
10.1016/j.jcv.2020.104444
10.3390/jcm10020191
10.1182/blood-2006-12-062695
10.1038/s41375-020-0891-0
10.3389/fimmu.2020.01625
10.1093/infdis/jiaa528
10.1016/j.thromres.2016.11.007
10.1186/s13045-020-00954-7
10.3389/fphar.2020.598308
10.1371/journal.pone.0028526
10.1001/jama.2020.8907
10.1161/CIRCULATIONAHA.120.048488
10.1126/scitranslmed.aan8292
10.1056/NEJMra2026131
10.1016/j.ebiom.2020.102925
10.1002/path.4935
10.1111/j.1538-7836.2007.02865.x
10.1160/TH07-02-0117
10.1182/blood.V87.6.2337.bloodjournal8762337
10.1016/S2665-9913(20)30121-1
10.1186/s12931-017-0651-5
10.1038/s41591-020-0901-9
10.1016/j.ejim.2020.06.006
10.1016/S2352-3026(20)30216-7
10.1186/s40560-014-0067-y
10.3389/fimmu.2019.02204
10.1016/S0140-6736(20)31305-2
10.1371/journal.pone.0045427
10.1186/s10020-020-00215-w
10.1007/s00428-020-02881-x
10.1016/j.thromres.2020.04.024
10.1016/j.trsl.2020.04.007
10.1016/j.jaci.2020.05.019
10.1038/s41591-020-1021-2
10.1097/CCE.0000000000000178
10.1007/s11239-020-02212-6
10.1111/j.1476-5381.2012.01847.x
10.1159/000492950
10.1097/CCM.0000000000004656
10.1016/j.jacc.2020.04.031
10.1111/jth.14850
10.1016/j.cell.2020.04.026
10.1002/path.1570
10.1016/j.jacc.2020.08.041
10.1084/jem.20201707
10.1172/JCI136094
10.1084/jem.178.2.579
10.1001/jama.2020.17052
10.1007/s00281-017-0629-x
10.3390/ijms21103625
10.1159/000356980
10.1007/s00011-020-01413-2
10.1126/sciadv.abe4724
10.1016/j.it.2007.02.006
10.1002/art.39247
10.1172/jci.insight.99445
10.1007/s11239-020-02162-z
10.1038/nri3345
10.1016/S2213-2600(20)30243-5
10.1002/jmv.23354
10.1038/s41581-020-00357-4
10.3389/fimmu.2018.01898
10.1038/s41569-020-00469-1
10.1016/j.jtho.2020.02.010
10.1161/01.ATV.19.9.2029
10.1055/s-0038-1655974
10.1515/cclm-2020-0369
10.1128/JVI.79.17.11062-11070.2005
10.1056/NEJMc2007575
10.1084/jem.20201129
10.1016/j.cub.2006.01.056
10.1371/journal.ppat.1002434
10.7326/M20-0533
10.1172/JCI83873
10.1016/j.eclinm.2020.100590
10.1016/j.thromres.2020.09.024
10.1160/TH17-09-0630
10.1055/s-0035-1570080
10.1016/j.healun.2020.03.012
10.1182/blood.2020007214
10.1016/S0140-6736(03)13413-7
10.1016/j.thromres.2020.04.014
10.1111/jth.14828
10.1111/jth.14858
10.1182/blood-2013-10-463646
10.1172/JCI141374
10.1016/S0140-6736(20)30183-5
10.1038/s41577-020-00470-2
10.1016/j.autrev.2020.102537
10.1016/j.cell.2019.10.027
10.1084/jem.20112322
10.1111/jth.14854
10.1073/pnas.1005743107
10.1007/s00134-020-06062-x
10.1128/mBio.01753-18
10.1016/j.ejim.2020.05.035
10.1080/14712598.2016.1227779
10.18632/oncotarget.24022
10.1007/s11239-020-02138-z
10.1371/journal.ppat.1001036
10.1002/jcp.30008
10.1016/j.it.2019.08.004
10.1002/path.1440
10.1172/jci.insight.140971
10.1093/cvr/cvaa093
10.1016/S1473-3099(20)30434-5
10.1097/ALN.0000000000002619
10.1084/jem.20200652
10.1182/blood.2020007252
10.1128/AAC.01043-16
10.1111/joim.13205
10.1161/CIRCRESAHA.120.317703
10.1182/blood.2020007008
10.1001/jama.2020.6825
10.1186/s13054-020-02880-z
ContentType Journal Article
Copyright Springer Nature Limited 2021
COPYRIGHT 2021 Nature Publishing Group
Springer Nature Limited 2021.
Copyright_xml – notice: Springer Nature Limited 2021
– notice: COPYRIGHT 2021 Nature Publishing Group
– notice: Springer Nature Limited 2021.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
ISR
3V.
7QR
7RV
7T5
7U9
7X7
7XB
88E
8AO
8C1
8FD
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FR3
FYUFA
GHDGH
GNUQQ
H94
HCIFZ
K9.
KB0
LK8
M0S
M1P
M7N
M7P
NAPCQ
P64
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/s41577-021-00536-9
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Chemoreception Abstracts
Nursing & Allied Health Database
Immunology Abstracts
Virology and AIDS Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Public Health Database
Technology Research Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One
ProQuest Central
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
AIDS and Cancer Research Abstracts
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biological Science Database
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
Proquest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
Technology Research Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Algology Mycology and Protozoology Abstracts (Microbiology C)
Health & Medical Research Collection
Biological Science Collection
AIDS and Cancer Research Abstracts
Chemoreception Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
Virology and AIDS Abstracts
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
Immunology Abstracts
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
ProQuest Central Student





Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1474-1741
EndPage 329
ExternalDocumentID PMC8023349
A660672148
33824483
10_1038_s41577_021_00536_9
Genre Research Support, Non-U.S. Gov't
Journal Article
Review
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
.55
0R~
123
29M
36B
39C
3V.
4.4
53G
70F
7RV
7X7
88E
8AO
8C1
8FE
8FH
8FI
8FJ
8R4
8R5
AAEEF
AARCD
AAWYQ
AAYZH
AAZLF
ABAWZ
ABDBF
ABJNI
ABLJU
ABNNU
ABUWG
ACGFS
ACIWK
ACPRK
ACRPL
ACUHS
ADBBV
ADNMO
AENEX
AEUYN
AFBBN
AFKRA
AFRAH
AFSHS
AGAYW
AGGDT
AGHTU
AHBCP
AHMBA
AHOSX
AHSBF
AIBTJ
AIYXT
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ARMCB
ASPBG
AVWKF
AXYYD
AZFZN
B0M
BBNVY
BENPR
BHPHI
BKEYQ
BKKNO
BPHCQ
BVXVI
CCPQU
CS3
DB5
DU5
EAD
EAP
EBC
EBD
EBS
EE.
EJD
EMB
EMK
EMOBN
EPL
ESX
EX3
EXGXG
F5P
FEDTE
FQGFK
FSGXE
FYUFA
HCIFZ
HMCUK
HVGLF
HZ~
IAO
IHR
IHW
INH
INR
ISR
ITC
L-9
LK8
M1P
M7P
N9A
NAPCQ
NNMJJ
O9-
ODYON
P2P
PQQKQ
PROAC
PSQYO
Q2X
RNR
RNT
RNTTT
SHXYY
SIXXV
SNYQT
SOJ
SV3
TAOOD
TBHMF
TDRGL
TSG
TUS
UKHRP
WOW
X7M
~8M
AAYXX
ABFSG
ACSTC
AEZWR
AFANA
AFHIU
AGSTI
AHWEU
AIXLP
ALPWD
ATHPR
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
PHGZM
PHGZT
7QR
7T5
7U9
7XB
8FD
8FK
AZQEC
DWQXO
FR3
GNUQQ
H94
K9.
M7N
P64
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c672t-74404bb4182fbd9a0c98b27a2d11e26bc2bf364813f9eacf88f4fad89946ed943
IEDL.DBID BENPR
ISICitedReferencesCount 706
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000637460400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1474-1733
1474-1741
IngestDate Tue Nov 04 02:00:38 EST 2025
Thu Oct 02 11:16:19 EDT 2025
Mon Oct 06 17:01:40 EDT 2025
Sat Nov 29 13:41:55 EST 2025
Sat Nov 29 10:09:52 EST 2025
Wed Nov 26 10:15:38 EST 2025
Thu May 22 21:20:10 EDT 2025
Wed Feb 19 02:26:55 EST 2025
Tue Nov 18 21:08:59 EST 2025
Sat Nov 29 06:24:32 EST 2025
Fri Feb 21 02:37:47 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c672t-74404bb4182fbd9a0c98b27a2d11e26bc2bf364813f9eacf88f4fad89946ed943
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0003-0823-8729
0000-0002-1026-6107
0000-0002-4747-5535
0000-0001-7387-3986
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8023349
PMID 33824483
PQID 2521813236
PQPubID 27582
PageCount 11
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8023349
proquest_miscellaneous_2509605689
proquest_journals_2521813236
gale_infotracmisc_A660672148
gale_infotracacademiconefile_A660672148
gale_incontextgauss_ISR_A660672148
gale_healthsolutions_A660672148
pubmed_primary_33824483
crossref_citationtrail_10_1038_s41577_021_00536_9
crossref_primary_10_1038_s41577_021_00536_9
springer_journals_10_1038_s41577_021_00536_9
PublicationCentury 2000
PublicationDate 2021-05-01
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-05-01
  day: 01
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Nature reviews. Immunology
PublicationTitleAbbrev Nat Rev Immunol
PublicationTitleAlternate Nat Rev Immunol
PublicationYear 2021
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Rodrigues (CR24) 2021; 218
Hickey, Kubes (CR157) 2009; 9
Wang (CR119) 2020; 18
Magro (CR52) 2020; 220
Zhang (CR53) 2020; 172
Teuwen, Geldhof, Pasut, Carmeliet (CR55) 2020; 20
Veras (CR89) 2020; 217
Bonaventura (CR162) 2018; 118
Gavriilaki, Brodsky (CR176) 2020; 130
Ciceri (CR79) 2020; 22
Escher, Breakey, Lammle (CR62) 2020; 190
Bergmann, Hammerschmidt (CR171) 2007; 98
Tang (CR152) 2020; 18
Leppkes (CR87) 2020; 58
Gralinski (CR177) 2018; 9
Barnes (CR129) 2020; 217
Carsana (CR8) 2020; 20
Siddiqi, Mehra (CR14) 2020; 39
McFadyen, Stevens, Peter (CR3) 2020; 127
Tagami (CR133) 2014; 2
Henry, de Oliveira, Benoit, Plebani, Lippi (CR26) 2020; 58
Tian (CR46) 2020; 15
Bradley (CR99) 2020; 396
Nadkarni (CR154) 2020; 76
Nicolai, Gaertner, Massberg (CR165) 2019; 40
Jansen (CR114) 1996; 87
Massberg (CR159) 2010; 16
Hottz (CR70) 2020; 136
Liu (CR125) 2020; 10
Helms (CR61) 2020; 46
Diurno (CR147) 2020; 24
Fox (CR6) 2020; 8
Buckley (CR15) 2020; 2
Goeijenbier (CR56) 2012; 84
Levi, van der Poll (CR60) 2017; 149
Mitsios, Arampatzioglou, Arelaki, Mitroulis, Ritis (CR81) 2016; 7
Bosmuller (CR97) 2020; 477
Mendoza-Pinto, Garcia-Carrasco, Cervera (CR93) 2018; 20
Reinhardt (CR168) 2008; 118
Manne (CR100) 2020; 136
Ammollo, Semeraro, Xu, Esmon, Esmon (CR164) 2011; 9
Cao (CR156) 2020; 146
Tay, Poh, Renia, MacAry, Ng (CR32) 2020; 20
Larsson (CR113) 2014; 6
Ranucci (CR4) 2020; 18
Ma, Kubes (CR166) 2008; 6
Blanco-Melo (CR22) 2020; 181
Risitano (CR146) 2020; 20
Bonetti, Lerman, Lerman (CR69) 2003; 23
Paar (CR108) 2021; 51
Fata-Hartley, Palmenberg (CR121) 2005; 79
Radermecker (CR88) 2020; 217
Prandoni (CR109) 2020; 196
Guo, Korteweg, McNutt, Gu (CR57) 2008; 133
Asakura, Ogawa (CR115) 2020; 18
McGonagle, O'Donnell, Sharif, Emery, Bridgewood (CR27) 2020; 2
Mastaglio (CR149) 2020; 215
Yan, Mackman, Kisiel, Stern, Pinsky (CR102) 1999; 19
Gazzaruso (CR39) 2020; 30
Stebbing (CR127) 2020; 7
Thomas (CR137) 2012; 119
Gattinoni, Chiumello, Rossi (CR76) 2020; 24
Flam, Wintzell, Ludvigsson, Martensson, Pasternak (CR112) 2021; 289
Lodigiani (CR37) 2020; 191
Lavezzo (CR13) 2020; 584
Martinelli (CR63) 2020; 193
Gattinoni (CR78) 2020; 46
Zeiher (CR131) 2004; 32
Kambas (CR161) 2012; 7
Iba, Warkentin, Thachil, Levi, Levy (CR45) 2021; 10
Guo, Rondina (CR167) 2019; 10
Mastellos (CR150) 2020; 220
Guggenberger, Wolz, Morrissey, Heesemann (CR175) 2012; 8
Wang (CR104) 2020; 7
Varga (CR47) 2020; 395
Fuchs (CR141) 2010; 107
Bendib (CR83) 2019; 130
Martinod, Wagner (CR163) 2014; 123
Ali (CR124) 2019; 10
Cavalli (CR128) 2020; 11
Rebetz, Semple, Kapur (CR82) 2018; 45
Schurink (CR9) 2020; 1
Beiter (CR173) 2006; 16
Lv (CR84) 2017; 18
Chousterman, Swirski, Weber (CR96) 2017; 39
Iba, Levy, Levi, Connors, Thachil (CR36) 2020; 48
Mitsios (CR126) 2020; 21
Jackson, Darbousset, Schoenwaelder (CR158) 2019; 133
Gupta (CR5) 2020; 26
Huang (CR16) 2020; 395
Weber, Chau, Egeblad, Barnes, Janowitz (CR139) 2020; 26
Schwameis, Schorgenhofer, Assinger, Steiner, Jilma (CR64) 2015; 113
Zuo (CR85) 2020; 5
La Rosee (CR155) 2020; 34
Goshua (CR35) 2020; 7
Gattinoni (CR77) 2020; 201
Aikawa, Kawasaki (CR132) 2014; 10
Ikeda (CR181) 1997; 77
de Bont, Boelens, Pruijn (CR91) 2019; 16
Wolfel (CR98) 2020; 581
Falcinelli (CR66) 2020
Levi, Hunt (CR107) 2020; 4
Ritis (CR182) 2006; 177
Zou (CR135) 2018; 9
McGonagle, Bridgewood, Ramanan, Meaney, Watad (CR151) 2021; 3
Peerschke, Reid, Ghebrehiwet (CR180) 1993; 178
Wolach (CR142) 2018; 10
Buchanan (CR172) 2006; 16
Pascarella (CR1) 2020; 288
Wiersinga, Rhodes, Cheng, Peacock, Prescott (CR11) 2020; 324
Chrysanthopoulou (CR74) 2017; 243
Alon (CR31) 2021; 21
Gu (CR75) 2021; 18
Yamamoto (CR116) 2016; 60
Gralinski (CR44) 2013; 4
Bikdeli (CR103) 2020; 75
Russo (CR110) 2020; 76
Vecchie (CR17) 2021; 236
Portincasa, Krawczyk, Machill, Lammert, Di Ciaula (CR42) 2020; 77
Xu (CR54) 2020; 8
Channappanavar, Perlman (CR95) 2017; 39
Yalavarthi (CR92) 2015; 67
Mir, D'Amico, Dasher, Tolwani, Valentine (CR40) 2021; 45
Toldo (CR23) 2021; 70
Mohamed, El-Shimy, Hadi (CR130) 2020; 24
Nicolai (CR71) 2020; 142
Java (CR144) 2020; 5
Kanthi, Knight, Zuo, Pinsky (CR120) 2020; 5
von Bruhl (CR160) 2012; 209
Semple, Aslam, Kim, Speck, Freedman (CR169) 2007; 109
Levi (CR72) 2016; 42
Barnes (CR106) 2020; 50
Zuo (CR94) 2020; 12
Middleton (CR80) 2020; 136
Schaller (CR48) 2020; 323
Ramlall (CR179) 2020; 26
Ding (CR58) 2003; 200
Perico (CR68) 2021; 17
McGonagle, Sharif, O'Regan, Bridgewood (CR50) 2020; 19
Bonaventura (CR2) 2020; 11
Kox, Waalders, Kooistra, Gerretsen, Pickkers (CR20) 2020; 324
Mehta (CR19) 2020; 395
Whyte, Morrow, Mitchell, Chowdary, Mutch (CR43) 2020; 18
Marini, Gattinoni (CR67) 2020; 323
Wang (CR41) 2020; 73
Lefrancais, Mallavia, Zhuo, Calfee, Looney (CR136) 2018; 3
Adachi (CR29) 2020; 26
Liao (CR30) 2020; 26
O'Flynn, Dixon, Faber Krol, Daha, van Kooten (CR90) 2014; 6
Engelmann, Massberg (CR10) 2013; 13
Paranjpe (CR105) 2020; 76
Fajgenbaum, June (CR18) 2020; 383
Panigada (CR34) 2020; 18
Zhang (CR101) 2020; 13
Tang, Li, Wang, Sun (CR33) 2020; 18
Liu (CR118) 2018; 9
Papayannopoulos, Staab, Zychlinsky (CR134) 2011; 6
Zaid (CR73) 2020; 127
Cheng (CR174) 2010; 6
Insel (CR123) 2012; 166
Zhang (CR145) 2020; 382
Bonaventura, Montecucco, Dallegri (CR117) 2016; 16
Leisman (CR21) 2020; 8
Gollomp (CR140) 2018; 3
Wichmann (CR7) 2020; 173
Huang (CR122) 2019; 179
Yost (CR143) 2016; 126
Hamming (CR59) 2004; 203
Skendros (CR86) 2020; 130
Annane (CR148) 2020; 28
Okur (CR138) 2020; 37
Markiewski, Nilsson, Ekdahl, Mollnes, Lambris (CR178) 2007; 28
Quartuccio (CR25) 2020; 129
Ayerbe, Risco, Ayis (CR153) 2020; 50
Chen, Hao (CR51) 2020; 116
Zhang (CR170) 2009; 182
Wang (CR28) 2020; 57
Iba, Connors, Levy (CR38) 2020; 69
Rossi, Coppi, Talarico, Boriani (CR111) 2020; 77
Berlin, Gulick, Martinez (CR12) 2020; 383
Guervilly (CR65) 2020; 222
Nicholls (CR49) 2003; 361
AM Risitano (536_CR146) 2020; 20
M Larsson (536_CR113) 2014; 6
D Annane (536_CR148) 2020; 28
M Levi (536_CR107) 2020; 4
Y Zuo (536_CR85) 2020; 5
P Skendros (536_CR86) 2020; 130
A Mitsios (536_CR126) 2020; 21
ED Hottz (536_CR70) 2020; 136
A Chrysanthopoulou (536_CR74) 2017; 243
H Zhang (536_CR53) 2020; 172
F La Rosee (536_CR155) 2020; 34
N Tang (536_CR152) 2020; 18
T Wang (536_CR104) 2020; 7
A Gupta (536_CR5) 2020; 26
Y Wang (536_CR41) 2020; 73
J Helms (536_CR61) 2020; 46
H Bosmuller (536_CR97) 2020; 477
SE Fox (536_CR6) 2020; 8
CT Ammollo (536_CR164) 2011; 9
PO Bonetti (536_CR69) 2003; 23
D Blanco-Melo (536_CR22) 2020; 181
K Beiter (536_CR173) 2006; 16
S Yalavarthi (536_CR92) 2015; 67
S Tian (536_CR46) 2020; 15
BT Bradley (536_CR99) 2020; 396
PA Insel (536_CR123) 2012; 166
J O'Flynn (536_CR90) 2014; 6
T Schaller (536_CR48) 2020; 323
F Diurno (536_CR147) 2020; 24
I Paranjpe (536_CR105) 2020; 76
D Wichmann (536_CR7) 2020; 173
C Radermecker (536_CR88) 2020; 217
LE Gralinski (536_CR44) 2013; 4
L Nicolai (536_CR165) 2019; 40
EA Middleton (536_CR80) 2020; 136
M Levi (536_CR60) 2017; 149
H Asakura (536_CR115) 2020; 18
K Ritis (536_CR182) 2006; 177
P Mehta (536_CR19) 2020; 395
AC Ma (536_CR166) 2008; 6
LE Gralinski (536_CR177) 2018; 9
L Gattinoni (536_CR76) 2020; 24
GM Thomas (536_CR137) 2012; 119
Y Zhang (536_CR145) 2020; 382
N Aikawa (536_CR132) 2014; 10
K Gollomp (536_CR140) 2018; 3
M Ranucci (536_CR4) 2020; 18
N Martinelli (536_CR63) 2020; 193
BK Manne (536_CR100) 2020; 136
CM de Bont (536_CR91) 2019; 16
R Rossi (536_CR111) 2020; 77
T Iba (536_CR45) 2021; 10
MMA Mohamed (536_CR130) 2020; 24
S Toldo (536_CR23) 2021; 70
JW Semple (536_CR169) 2007; 109
V Ramlall (536_CR179) 2020; 26
S Mastaglio (536_CR149) 2020; 215
B Schurink (536_CR9) 2020; 1
JD McFadyen (536_CR3) 2020; 127
M Yamamoto (536_CR116) 2016; 60
C Gazzaruso (536_CR39) 2020; 30
MM Markiewski (536_CR178) 2007; 28
CL Fata-Hartley (536_CR121) 2005; 79
LA Teuwen (536_CR55) 2020; 20
L Gattinoni (536_CR77) 2020; 201
L Gattinoni (536_CR78) 2020; 46
A Bonaventura (536_CR2) 2020; 11
B Engelmann (536_CR10) 2013; 13
M Leppkes (536_CR87) 2020; 58
L Nicolai (536_CR71) 2020; 142
T Iba (536_CR38) 2020; 69
R Alon (536_CR31) 2021; 21
J Stebbing (536_CR127) 2020; 7
J Rebetz (536_CR82) 2018; 45
V Russo (536_CR110) 2020; 76
L Ayerbe (536_CR153) 2020; 50
ML von Bruhl (536_CR160) 2012; 209
PM Jansen (536_CR114) 1996; 87
DC Fajgenbaum (536_CR18) 2020; 383
BG Chousterman (536_CR96) 2017; 39
DC Mastellos (536_CR150) 2020; 220
P Portincasa (536_CR42) 2020; 77
CS Whyte (536_CR43) 2020; 18
Y Zuo (536_CR94) 2020; 12
V Paar (536_CR108) 2021; 51
BM Henry (536_CR26) 2020; 58
MJ Hickey (536_CR157) 2009; 9
FP Veras (536_CR89) 2020; 217
LF Buckley (536_CR15) 2020; 2
Z Xu (536_CR54) 2020; 8
C Wang (536_CR28) 2020; 57
G Pascarella (536_CR1) 2020; 288
S Massberg (536_CR159) 2010; 16
T Adachi (536_CR29) 2020; 26
L Chen (536_CR51) 2020; 116
B Huang (536_CR122) 2019; 179
JJ Marini (536_CR67) 2020; 323
Y Zaid (536_CR73) 2020; 127
A Vecchie (536_CR17) 2021; 236
M Kox (536_CR20) 2020; 324
E Falcinelli (536_CR66) 2020
JM Nicholls (536_CR49) 2003; 361
E Lefrancais (536_CR136) 2018; 3
GN Nadkarni (536_CR154) 2020; 76
A Java (536_CR144) 2020; 5
DA Berlin (536_CR12) 2020; 383
F Ciceri (536_CR79) 2020; 22
D McGonagle (536_CR151) 2021; 3
SX Gu (536_CR75) 2021; 18
SF Yan (536_CR102) 1999; 19
S Bergmann (536_CR171) 2007; 98
TA Fuchs (536_CR141) 2010; 107
BG Zeiher (536_CR131) 2004; 32
G Goshua (536_CR35) 2020; 7
GD Barnes (536_CR106) 2020; 50
L Quartuccio (536_CR25) 2020; 129
Y Guo (536_CR57) 2008; 133
WJ Wiersinga (536_CR11) 2020; 324
M Liao (536_CR30) 2020; 26
Y Kanthi (536_CR120) 2020; 5
D McGonagle (536_CR27) 2020; 2
M Schwameis (536_CR64) 2015; 113
Y Zou (536_CR135) 2018; 9
K Ikeda (536_CR181) 1997; 77
C Magro (536_CR52) 2020; 220
C Guervilly (536_CR65) 2020; 222
DE Leisman (536_CR21) 2020; 8
E Lavezzo (536_CR13) 2020; 584
MZ Tay (536_CR32) 2020; 20
B Flam (536_CR112) 2021; 289
L Carsana (536_CR8) 2020; 20
Y Cao (536_CR156) 2020; 146
A Mitsios (536_CR81) 2016; 7
M Levi (536_CR72) 2016; 42
RA Ali (536_CR124) 2019; 10
HK Siddiqi (536_CR14) 2020; 39
X Lv (536_CR84) 2017; 18
X Liu (536_CR125) 2020; 10
I Hamming (536_CR59) 2004; 203
K Martinod (536_CR163) 2014; 123
M Panigada (536_CR34) 2020; 18
N Mir (536_CR40) 2021; 45
B Bikdeli (536_CR103) 2020; 75
R Channappanavar (536_CR95) 2017; 39
P Prandoni (536_CR109) 2020; 196
S Zhang (536_CR101) 2020; 13
C Huang (536_CR16) 2020; 395
C Guggenberger (536_CR175) 2012; 8
R Wolfel (536_CR98) 2020; 581
A Bonaventura (536_CR117) 2016; 16
V Papayannopoulos (536_CR134) 2011; 6
HK Okur (536_CR138) 2020; 37
C Liu (536_CR118) 2018; 9
N Tang (536_CR33) 2020; 18
M Goeijenbier (536_CR56) 2012; 84
BJ Barnes (536_CR129) 2020; 217
D McGonagle (536_CR50) 2020; 19
SP Jackson (536_CR158) 2019; 133
EI Peerschke (536_CR180) 1993; 178
Z Varga (536_CR47) 2020; 395
I Bendib (536_CR83) 2019; 130
O Wolach (536_CR142) 2018; 10
T Iba (536_CR36) 2020; 48
A Bonaventura (536_CR162) 2018; 118
CC Yost (536_CR143) 2016; 126
L Perico (536_CR68) 2021; 17
K Kambas (536_CR161) 2012; 7
C Reinhardt (536_CR168) 2008; 118
TS Rodrigues (536_CR24) 2021; 218
J Wang (536_CR119) 2020; 18
G Zhang (536_CR170) 2009; 182
T Tagami (536_CR133) 2014; 2
E Gavriilaki (536_CR176) 2020; 130
Y Ding (536_CR58) 2003; 200
AG Cheng (536_CR174) 2010; 6
AG Weber (536_CR139) 2020; 26
C Lodigiani (536_CR37) 2020; 191
L Guo (536_CR167) 2019; 10
JT Buchanan (536_CR172) 2006; 16
G Cavalli (536_CR128) 2020; 11
R Escher (536_CR62) 2020; 190
C Mendoza-Pinto (536_CR93) 2018; 20
34677789 - Intern Emerg Med. 2022 Mar;17(2):593-596
References_xml – volume: 26
  start-page: 842
  year: 2020
  end-page: 844
  ident: CR30
  article-title: Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
  publication-title: Nat. Med.
– volume: 10
  start-page: eaan8292
  year: 2018
  ident: CR142
  article-title: Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms
  publication-title: Sci. Transl Med.
– volume: 58
  start-page: 1021
  year: 2020
  end-page: 1028
  ident: CR26
  article-title: Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
  publication-title: Clin. Chem. Lab. Med.
– volume: 2
  start-page: e437
  year: 2020
  end-page: e445
  ident: CR27
  article-title: Immune mechanisms of pulmonary intravascular coagulopathy in COVID-19 pneumonia
  publication-title: Lancet Rheumatol.
– volume: 11
  start-page: 598308
  year: 2020
  ident: CR128
  article-title: Repurposing of biologic and targeted synthetic anti-rheumatic drugs in COVID-19 and hyper-inflammation: a comprehensive review of available and emerging evidence at the peak of the pandemic
  publication-title: Front. Pharmacol.
– volume: 26
  start-page: 91
  year: 2020
  ident: CR139
  article-title: Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series
  publication-title: Mol. Med.
– volume: 129
  start-page: 104444
  year: 2020
  ident: CR25
  article-title: Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: results from a single Italian centre study on tocilizumab versus standard of care
  publication-title: J. Clin. Virol.
– volume: 20
  start-page: 1135
  year: 2020
  end-page: 1140
  ident: CR8
  article-title: Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
  publication-title: Lancet Infect. Dis.
– volume: 324
  start-page: 1565
  year: 2020
  end-page: 1567
  ident: CR20
  article-title: Cytokine levels in critically ill patients with COVID-19 and other conditions
  publication-title: JAMA
– volume: 51
  start-page: 226
  year: 2021
  end-page: 231
  ident: CR108
  article-title: Anti-coagulation for COVID-19 treatment: both anti-thrombotic and anti-inflammatory?
  publication-title: J. Thromb. Thrombolysis
– volume: 98
  start-page: 512
  year: 2007
  end-page: 520
  ident: CR171
  article-title: Fibrinolysis and host response in bacterial infections
  publication-title: Thromb. Haemost.
– year: 2020
  ident: CR66
  article-title: Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2020.11.041
– volume: 123
  start-page: 2768
  year: 2014
  end-page: 2776
  ident: CR163
  article-title: Thrombosis: tangled up in NETs
  publication-title: Blood
– volume: 16
  start-page: 401
  year: 2006
  end-page: 407
  ident: CR173
  article-title: An endonuclease allows to escape from neutrophil extracellular traps
  publication-title: Curr. Biol.
– volume: 26
  start-page: 1017
  year: 2020
  end-page: 1032
  ident: CR5
  article-title: Extrapulmonary manifestations of COVID-19
  publication-title: Nat. Med.
– volume: 10
  start-page: 191
  year: 2021
  ident: CR45
  article-title: Proposal of the definition for COVID-19-associated coagulopathy
  publication-title: J. Clin. Med.
– volume: 133
  start-page: 906
  year: 2019
  end-page: 918
  ident: CR158
  article-title: Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms
  publication-title: Blood
– volume: 23
  start-page: 168
  year: 2003
  end-page: 175
  ident: CR69
  article-title: Endothelial dysfunction: a marker of atherosclerotic risk
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 6
  start-page: 222ra217
  year: 2014
  ident: CR113
  article-title: A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk
  publication-title: Sci. Transl Med.
– volume: 22
  start-page: 95
  year: 2020
  end-page: 97
  ident: CR79
  article-title: Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis
  publication-title: Crit. Care Resusc.
– volume: 3
  year: 2018
  ident: CR136
  article-title: Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury
  publication-title: JCI Insight
– volume: 2
  year: 2020
  ident: CR15
  article-title: Role for anti-cytokine therapies in severe coronavirus disease 2019
  publication-title: Crit. Care Explor.
– volume: 5
  year: 2020
  ident: CR144
  article-title: The complement system in COVID-19: friend and foe?
  publication-title: JCI Insight
– volume: 173
  start-page: 268
  year: 2020
  end-page: 277
  ident: CR7
  article-title: Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study
  publication-title: Ann. Intern. Med.
– volume: 16
  start-page: 887
  year: 2010
  end-page: 896
  ident: CR159
  article-title: Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases
  publication-title: Nat. Med.
– volume: 2
  year: 2014
  ident: CR133
  article-title: Effect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: a post hoc analysis of the PiCCO Pulmonary Edema Study
  publication-title: J. Intensive Care
– volume: 323
  start-page: 2518
  year: 2020
  end-page: 2520
  ident: CR48
  article-title: Postmortem examination of patients with COVID-19
  publication-title: JAMA
– volume: 217
  year: 2020
  ident: CR129
  article-title: Targeting potential drivers of COVID-19: neutrophil extracellular traps
  publication-title: J. Exp. Med.
– volume: 40
  start-page: 922
  year: 2019
  end-page: 938
  ident: CR165
  article-title: Platelets in host defense: experimental and clinical insights
  publication-title: Trends Immunol.
– volume: 19
  start-page: 102537
  year: 2020
  ident: CR50
  article-title: The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease
  publication-title: Autoimmun. Rev.
– volume: 16
  start-page: 1323
  year: 2016
  end-page: 1340
  ident: CR117
  article-title: Update on the effects of treatment with recombinant tissue-type plasminogen activator (rt-PA) in acute ischemic stroke
  publication-title: Expert. Opin. Biol. Ther.
– volume: 4
  start-page: 744
  year: 2020
  end-page: 751
  ident: CR107
  article-title: Thrombosis and coagulopathy in COVID-19: an illustrated review
  publication-title: Res. Pract. Thromb. Haemost.
– volume: 7
  start-page: 678
  year: 2016
  ident: CR81
  article-title: NETopathies? Unraveling the dark side of old diseases through neutrophils
  publication-title: Front. Immunol.
– volume: 39
  start-page: 529
  year: 2017
  end-page: 539
  ident: CR95
  article-title: Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
  publication-title: Semin. Immunopathol.
– volume: 191
  start-page: 9
  year: 2020
  end-page: 14
  ident: CR37
  article-title: Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
  publication-title: Thromb. Res.
– volume: 76
  start-page: 122
  year: 2020
  end-page: 124
  ident: CR105
  article-title: Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19
  publication-title: J. Am. Coll. Cardiol.
– volume: 76
  start-page: 369
  year: 2020
  end-page: 371
  ident: CR110
  article-title: Fondaparinux use in patients with COVID-19: a preliminary multicenter real-world experience
  publication-title: J. Cardiovasc. Pharmacol.
– volume: 118
  start-page: 1110
  year: 2008
  end-page: 1122
  ident: CR168
  article-title: Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation
  publication-title: J. Clin. Invest.
– volume: 383
  start-page: 2451
  year: 2020
  end-page: 2460
  ident: CR12
  article-title: Severe COVID-19
  publication-title: N. Engl. J. Med.
– volume: 42
  start-page: 252
  year: 2016
  end-page: 257
  ident: CR72
  article-title: Platelets in critical illness
  publication-title: Semin. Thromb. Hemost.
– volume: 7
  start-page: e575
  year: 2020
  end-page: e582
  ident: CR35
  article-title: Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
  publication-title: Lancet Haematol.
– volume: 109
  start-page: 4803
  year: 2007
  end-page: 4805
  ident: CR169
  article-title: Platelet-bound lipopolysaccharide enhances Fc receptor-mediated phagocytosis of IgG-opsonized platelets
  publication-title: Blood
– volume: 73
  start-page: 807
  year: 2020
  end-page: 816
  ident: CR41
  article-title: SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19
  publication-title: J. Hepatol.
– volume: 200
  start-page: 282
  year: 2003
  end-page: 289
  ident: CR58
  article-title: The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
  publication-title: J. Pathol.
– volume: 190
  start-page: 62
  year: 2020
  ident: CR62
  article-title: Severe COVID-19 infection associated with endothelial activation
  publication-title: Thromb. Res.
– volume: 217
  year: 2020
  ident: CR89
  article-title: SARS-CoV-2-triggered neutrophil extracellular traps mediate COVID-19 pathology
  publication-title: J. Exp. Med.
– volume: 177
  start-page: 4794
  year: 2006
  end-page: 4802
  ident: CR182
  article-title: A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways
  publication-title: J. Immunol.
– volume: 18
  start-page: 194
  year: 2021
  end-page: 209
  ident: CR75
  article-title: Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
  publication-title: Nat. Rev. Cardiol.
– volume: 220
  start-page: 108598
  year: 2020
  ident: CR150
  article-title: Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy
  publication-title: Clin. Immunol.
– volume: 70
  start-page: 7
  year: 2021
  end-page: 10
  ident: CR23
  article-title: Inflammasome formation in the lungs of patients with fatal COVID-19
  publication-title: Inflamm. Res.
– volume: 3
  year: 2018
  ident: CR140
  article-title: Neutrophil accumulation and NET release contribute to thrombosis in HIT
  publication-title: JCI Insight
– volume: 181
  start-page: 1036
  year: 2020
  end-page: 1045.e9
  ident: CR22
  article-title: Imbalanced host response to SARS-CoV-2 drives development of COVID-19
  publication-title: Cell
– volume: 20
  start-page: 363
  year: 2020
  end-page: 374
  ident: CR32
  article-title: The trinity of COVID-19: immunity, inflammation and intervention
  publication-title: Nat. Rev. Immunol.
– volume: 136
  start-page: 1169
  year: 2020
  end-page: 1179
  ident: CR80
  article-title: Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome
  publication-title: Blood
– volume: 126
  start-page: 3783
  year: 2016
  end-page: 3798
  ident: CR143
  article-title: Neonatal NET-inhibitory factor and related peptides inhibit neutrophil extracellular trap formation
  publication-title: J. Clin. Invest.
– volume: 136
  start-page: 1317
  year: 2020
  end-page: 1329
  ident: CR100
  article-title: Platelet gene expression and function in patients with COVID-19
  publication-title: Blood
– volume: 50
  start-page: 298
  year: 2020
  end-page: 301
  ident: CR153
  article-title: The association between treatment with heparin and survival in patients with COVID-19
  publication-title: J. Thromb. Thrombolysis
– volume: 18
  start-page: 165
  year: 2017
  ident: CR84
  article-title: Extracellular histones are clinically relevant mediators in the pathogenesis of acute respiratory distress syndrome
  publication-title: Respir. Res.
– volume: 76
  start-page: 1815
  year: 2020
  end-page: 1826
  ident: CR154
  article-title: Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19
  publication-title: J. Am. Coll. Cardiol.
– volume: 209
  start-page: 819
  year: 2012
  end-page: 835
  ident: CR160
  article-title: Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo
  publication-title: J. Exp. Med.
– volume: 236
  start-page: 1638
  year: 2021
  end-page: 1657
  ident: CR17
  article-title: IL-18 and infections: is there a role for targeted therapies?
  publication-title: J. Cell Physiol.
– volume: 45
  start-page: 100731
  year: 2021
  ident: CR40
  article-title: Understanding the andromeda strain — the role of cytokine release, coagulopathy and antithrombin III in SARS-CoV2 critical illness
  publication-title: Blood Rev.
– volume: 21
  start-page: 3625
  year: 2020
  ident: CR126
  article-title: Ticagrelor exerts immune-modulatory effect by attenuating neutrophil extracellular traps
  publication-title: Int. J. Mol. Sci.
– volume: 584
  start-page: 425
  year: 2020
  end-page: 429
  ident: CR13
  article-title: Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo′
  publication-title: Nature
– volume: 84
  start-page: 1680
  year: 2012
  end-page: 1696
  ident: CR56
  article-title: Review: Viral infections and mechanisms of thrombosis and bleeding
  publication-title: J. Med. Virol.
– volume: 6
  year: 2010
  ident: CR174
  article-title: Contribution of coagulases towards disease and protective immunity
  publication-title: PLoS Pathog.
– volume: 289
  start-page: 411
  year: 2021
  end-page: 419
  ident: CR112
  article-title: Direct oral anticoagulant use and risk of severe COVID-19
  publication-title: J. Intern. Med.
– volume: 396
  start-page: 320
  year: 2020
  end-page: 332
  ident: CR99
  article-title: Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series
  publication-title: Lancet
– volume: 9
  year: 2018
  ident: CR177
  article-title: Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis
  publication-title: mBio
– volume: 383
  start-page: 2255
  year: 2020
  end-page: 2273
  ident: CR18
  article-title: Cytokine storm
  publication-title: N. Engl. J. Med.
– volume: 18
  start-page: 1548
  year: 2020
  end-page: 1555
  ident: CR43
  article-title: Fibrinolytic abnormalities in acute respiratory distress syndrome (ARDS) and versatility of thrombolytic drugs to treat COVID-19
  publication-title: J. Thromb. Haemost.
– volume: 20
  start-page: 62
  year: 2018
  ident: CR93
  article-title: Role of infectious diseases in the antiphospholipid syndrome (including its catastrophic variant)
  publication-title: Curr. Rheumatol. Rep.
– volume: 39
  start-page: 405
  year: 2020
  end-page: 407
  ident: CR14
  article-title: COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal
  publication-title: J. Heart Lung Transpl.
– volume: 243
  start-page: 111
  year: 2017
  end-page: 122
  ident: CR74
  article-title: Interferon λ1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation
  publication-title: J. Pathol.
– volume: 218
  year: 2021
  ident: CR24
  article-title: Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
  publication-title: J. Exp. Med.
– volume: 201
  start-page: 1299
  year: 2020
  end-page: 1300
  ident: CR77
  article-title: COVID-19 does not lead to a ‘typical’ acute respiratory distress syndrome
  publication-title: Am. J. Respir. Crit. Care Med.
– volume: 26
  start-page: 1609
  year: 2020
  end-page: 1615
  ident: CR179
  article-title: Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
  publication-title: Nat. Med.
– volume: 130
  start-page: 2152
  year: 2020
  end-page: 2163
  ident: CR176
  article-title: Complementopathies and precision medicine
  publication-title: J. Clin. Invest.
– volume: 45
  start-page: 290
  year: 2018
  end-page: 298
  ident: CR82
  article-title: The pathogenic involvement of neutrophils in acute respiratory distress syndrome and transfusion-related acute lung injury
  publication-title: Transfus. Med. Hemother
– volume: 581
  start-page: 465
  year: 2020
  end-page: 469
  ident: CR98
  article-title: Virological assessment of hospitalized patients with COVID-2019
  publication-title: Nature
– volume: 77
  start-page: 18
  year: 2020
  end-page: 24
  ident: CR42
  article-title: Hepatic consequences of COVID-19 infection. Lapping or biting?
  publication-title: Eur. J. Intern. Med.
– volume: 60
  start-page: 6532
  year: 2016
  end-page: 6539
  ident: CR116
  article-title: Identification of nafamostat as a potent inhibitor of Middle East respiratory syndrome coronavirus S protein-mediated membrane fusion using the split-protein-based cell–cell fusion assay
  publication-title: Antimicrob. Agents Chemother.
– volume: 9
  start-page: 364
  year: 2009
  end-page: 375
  ident: CR157
  article-title: Intravascular immunity: the host–pathogen encounter in blood vessels
  publication-title: Nat. Rev. Immunol.
– volume: 19
  start-page: 2029
  year: 1999
  end-page: 2035
  ident: CR102
  article-title: Hypoxia/hypoxemia-induced activation of the procoagulant pathways and the pathogenesis of ischemia-associated thrombosis
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 18
  start-page: 844
  year: 2020
  end-page: 847
  ident: CR33
  article-title: Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
  publication-title: J. Thromb. Haemost.
– volume: 13
  start-page: 120
  year: 2020
  ident: CR101
  article-title: SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
  publication-title: J. Hematol. Oncol.
– volume: 32
  start-page: 1695
  year: 2004
  end-page: 1702
  ident: CR131
  article-title: Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study
  publication-title: Crit. Care Med.
– volume: 57
  start-page: 102833
  year: 2020
  ident: CR28
  article-title: Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients
  publication-title: EBioMedicine
– volume: 3
  start-page: e224
  year: 2021
  end-page: e233
  ident: CR151
  article-title: COVID-19 vasculitis and novel vasculitis mimics
  publication-title: Lancet Rheumatol.
– volume: 118
  start-page: 6
  year: 2018
  end-page: 27
  ident: CR162
  article-title: The pathophysiological role of neutrophil extracellular traps in inflammatory diseases
  publication-title: Thromb. Haemost.
– volume: 34
  start-page: 1805
  year: 2020
  end-page: 1815
  ident: CR155
  article-title: The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
  publication-title: Leukemia
– volume: 196
  start-page: 395
  year: 2020
  end-page: 397
  ident: CR109
  article-title: The hazard of fondaparinux in non-critically ill patients with COVID-19: retrospective controlled study versus enoxaparin
  publication-title: Thromb. Res.
– volume: 6
  year: 2011
  ident: CR134
  article-title: Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving DNase therapy
  publication-title: PLoS ONE
– volume: 18
  start-page: 1094
  year: 2020
  end-page: 1099
  ident: CR152
  article-title: Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
  publication-title: J. Thromb. Haemost.
– volume: 146
  start-page: 137
  year: 2020
  end-page: 146.e3
  ident: CR156
  article-title: Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): a multicenter, single-blind, randomized controlled trial
  publication-title: J. Allergy Clin. Immunol.
– volume: 28
  start-page: 184
  year: 2007
  end-page: 192
  ident: CR178
  article-title: Complement and coagulation: strangers or partners in crime?
  publication-title: Trends Immunol.
– volume: 149
  start-page: 38
  year: 2017
  end-page: 44
  ident: CR60
  article-title: Coagulation and sepsis
  publication-title: Thromb. Res.
– volume: 16
  start-page: 19
  year: 2019
  end-page: 27
  ident: CR91
  article-title: NETosis, complement, and coagulation: a triangular relationship
  publication-title: Cell Mol. Immunol.
– volume: 361
  start-page: 1773
  year: 2003
  end-page: 1778
  ident: CR49
  article-title: Lung pathology of fatal severe acute respiratory syndrome
  publication-title: Lancet
– volume: 8
  start-page: 420
  year: 2020
  end-page: 422
  ident: CR54
  article-title: Pathological findings of COVID-19 associated with acute respiratory distress syndrome
  publication-title: Lancet Respir. Med.
– volume: 20
  start-page: 343
  year: 2020
  end-page: 344
  ident: CR146
  article-title: Complement as a target in COVID-19?
  publication-title: Nat. Rev. Immunol.
– volume: 21
  start-page: 49
  year: 2021
  end-page: 64
  ident: CR31
  article-title: Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
  publication-title: Nat. Rev. Immunol.
– volume: 10
  start-page: 621
  year: 2014
  end-page: 629
  ident: CR132
  article-title: Clinical utility of the neutrophil elastase inhibitor sivelestat for the treatment of acute respiratory distress syndrome
  publication-title: Ther. Clin. Risk Manag.
– volume: 7
  start-page: e362
  year: 2020
  end-page: e363
  ident: CR104
  article-title: Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
  publication-title: Lancet Haematol.
– volume: 28
  start-page: 100590
  year: 2020
  ident: CR148
  article-title: Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: a proof-of-concept study
  publication-title: EClinicalMedicine
– volume: 166
  start-page: 447
  year: 2012
  end-page: 456
  ident: CR123
  article-title: cAMP and Epac in the regulation of tissue fibrosis
  publication-title: Br. J. Pharmacol.
– volume: 48
  start-page: 1358
  year: 2020
  end-page: 1364
  ident: CR36
  article-title: Coagulopathy of coronavirus disease 2019
  publication-title: Crit. Care Med.
– volume: 8
  start-page: 681
  year: 2020
  end-page: 686
  ident: CR6
  article-title: Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans
  publication-title: Lancet Respir. Med.
– volume: 79
  start-page: 11062
  year: 2005
  end-page: 11070
  ident: CR121
  article-title: Dipyridamole reversibly inhibits mengovirus RNA replication
  publication-title: J. Virol.
– volume: 178
  start-page: 579
  year: 1993
  end-page: 587
  ident: CR180
  article-title: Platelet activation by C1q results in the induction of αIIb/β3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity
  publication-title: J. Exp. Med.
– volume: 58
  start-page: 102925
  year: 2020
  ident: CR87
  article-title: Vascular occlusion by neutrophil extracellular traps in COVID-19
  publication-title: EBioMedicine
– volume: 395
  start-page: 497
  year: 2020
  end-page: 506
  ident: CR16
  article-title: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
  publication-title: Lancet
– volume: 46
  start-page: 1099
  year: 2020
  end-page: 1102
  ident: CR78
  article-title: COVID-19 pneumonia: different respiratory treatments for different phenotypes?
  publication-title: Intensive Care Med.
– volume: 220
  start-page: 1
  year: 2020
  end-page: 13
  ident: CR52
  article-title: Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases
  publication-title: Transl Res.
– volume: 50
  start-page: 72
  year: 2020
  end-page: 81
  ident: CR106
  article-title: Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum
  publication-title: J. Thromb. Thrombolysis
– volume: 7
  start-page: eabe4724
  year: 2020
  ident: CR127
  article-title: JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality
  publication-title: Sci. Adv.
– volume: 10
  start-page: 2204
  year: 2019
  ident: CR167
  article-title: The era of thromboinflammation: platelets are dynamic sensors and effector cells during infectious diseases
  publication-title: Front. Immunol.
– volume: 30
  start-page: 1914
  year: 2020
  end-page: 1919
  ident: CR39
  article-title: Association between antithrombin and mortality in patients with COVID-19. A possible link with obesity
  publication-title: Nutr. Metab. Cardiovasc. Dis.
– volume: 77
  start-page: 158
  year: 2020
  end-page: 160
  ident: CR111
  article-title: Protective role of chronic treatment with direct oral anticoagulants in elderly patients affected by interstitial pneumonia in COVID-19 era
  publication-title: Eur. J. Intern. Med.
– volume: 10
  start-page: 1205
  year: 2020
  end-page: 1215
  ident: CR125
  article-title: Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
  publication-title: Acta Pharm. Sin. B
– volume: 324
  start-page: 782
  year: 2020
  end-page: 793
  ident: CR11
  article-title: Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review
  publication-title: JAMA
– volume: 15
  start-page: 700
  year: 2020
  end-page: 704
  ident: CR46
  article-title: Pulmonary pathology of early-phase 2019 novel coronavirus (COVID-19) pneumonia in two patients with lung cancer
  publication-title: J. Thorac. Oncol.
– volume: 172
  start-page: 629
  year: 2020
  end-page: 632
  ident: CR53
  article-title: Histopathologic changes and SARS-CoV-2 immunostaining in the lung of a patient with COVID-19
  publication-title: Ann. Intern. Med.
– volume: 12
  start-page: eabd3876
  year: 2020
  ident: CR94
  article-title: Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
  publication-title: Sci. Transl Med.
– volume: 116
  start-page: 1932
  year: 2020
  end-page: 1936
  ident: CR51
  article-title: The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular disease
  publication-title: Cardiovasc. Res.
– volume: 20
  start-page: 389
  year: 2020
  end-page: 391
  ident: CR55
  article-title: COVID-19: the vasculature unleashed
  publication-title: Nat. Rev. Immunol.
– volume: 17
  start-page: 46
  year: 2021
  end-page: 64
  ident: CR68
  article-title: Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
  publication-title: Nat. Rev. Nephrol.
– volume: 119
  start-page: 6335
  year: 2012
  end-page: 6343
  ident: CR137
  article-title: Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice
  publication-title: Blood
– volume: 142
  start-page: 1176
  year: 2020
  end-page: 1189
  ident: CR71
  article-title: Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy
  publication-title: Circulation
– volume: 46
  start-page: 1089
  year: 2020
  end-page: 1098
  ident: CR61
  article-title: High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
  publication-title: Intensive Care Med.
– volume: 323
  start-page: 2329
  year: 2020
  end-page: 2330
  ident: CR67
  article-title: Management of COVID-19 respiratory distress
  publication-title: JAMA
– volume: 217
  year: 2020
  ident: CR88
  article-title: Neutrophil extracellular traps infiltrate the lung airway, interstitial, and vascular compartments in severe COVID-19
  publication-title: J. Exp. Med.
– volume: 215
  start-page: 108450
  year: 2020
  ident: CR149
  article-title: The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
  publication-title: Clin. Immunol.
– volume: 18
  start-page: 1521
  year: 2020
  end-page: 1522
  ident: CR115
  article-title: Potential of heparin and nafamostat combination therapy for COVID-19
  publication-title: J. Thromb. Haemost.
– volume: 136
  start-page: 1330
  year: 2020
  end-page: 1341
  ident: CR70
  article-title: Platelet activation and platelet–monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
  publication-title: Blood
– volume: 69
  start-page: 1181
  year: 2020
  end-page: 1189
  ident: CR38
  article-title: The coagulopathy, endotheliopathy, and vasculitis of COVID-19
  publication-title: Inflamm. Res.
– volume: 127
  start-page: 571
  year: 2020
  end-page: 587
  ident: CR3
  article-title: The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications
  publication-title: Circ. Res.
– volume: 130
  start-page: 581
  year: 2019
  end-page: 591
  ident: CR83
  article-title: Neutrophil extracellular traps are elevated in patients with pneumonia-related acute respiratory distress syndrome
  publication-title: Anesthesiology
– volume: 6
  start-page: 415
  year: 2008
  end-page: 420
  ident: CR166
  article-title: Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis
  publication-title: J. Thromb. Haemost.
– volume: 75
  start-page: 2950
  year: 2020
  end-page: 2973
  ident: CR103
  article-title: COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC State-of-the-Art Review
  publication-title: J. Am. Coll. Cardiol.
– volume: 18
  start-page: 1752
  year: 2020
  end-page: 1755
  ident: CR119
  article-title: Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series
  publication-title: J. Thromb. Haemost.
– volume: 182
  start-page: 7997
  year: 2009
  end-page: 8004
  ident: CR170
  article-title: Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway
  publication-title: J. Immunol.
– volume: 10
  year: 2019
  ident: CR124
  article-title: Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome
  publication-title: Nat. Commun.
– volume: 179
  start-page: 1160
  year: 2019
  end-page: 1176.e24
  ident: CR122
  article-title: Mucosal profiling of pediatric-onset colitis and IBD reveals common pathogenics and therapeutic pathways
  publication-title: Cell
– volume: 477
  start-page: 349
  year: 2020
  end-page: 357
  ident: CR97
  article-title: The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation
  publication-title: Virchows Arch.
– volume: 24
  year: 2020
  ident: CR130
  article-title: Neutrophil elastase inhibitors: a potential prophylactic treatment option for SARS-CoV-2-induced respiratory complications?
  publication-title: Crit. Care
– volume: 9
  start-page: 1795
  year: 2011
  end-page: 1803
  ident: CR164
  article-title: Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation
  publication-title: J. Thromb. Haemost.
– volume: 395
  start-page: 1033
  year: 2020
  end-page: 1034
  ident: CR19
  article-title: COVID-19: consider cytokine storm syndromes and immunosuppression
  publication-title: Lancet
– volume: 77
  start-page: 394
  year: 1997
  end-page: 398
  ident: CR181
  article-title: C5a induces tissue factor activity on endothelial cells
  publication-title: Thromb. Haemost.
– volume: 127
  start-page: 1404
  year: 2020
  end-page: 1418
  ident: CR73
  article-title: Platelets can associate with SARS-Cov-2 RNA and are hyperactivated in COVID-19
  publication-title: Circ. Res.
– volume: 11
  start-page: 1625
  year: 2020
  ident: CR2
  article-title: Targeting GM-CSF in COVID-19 pneumonia: rationale and strategies
  publication-title: Front. Immunol.
– volume: 24
  start-page: 4040
  year: 2020
  end-page: 4047
  ident: CR147
  article-title: Eculizumab treatment in patients with COVID-19: preliminary results from real life ASL Napoli 2 Nord experience
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 8
  start-page: 1233
  year: 2020
  end-page: 1244
  ident: CR21
  article-title: Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
  publication-title: Lancet Respir. Med.
– volume: 193
  start-page: 170
  year: 2020
  end-page: 172
  ident: CR63
  article-title: A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19
  publication-title: Thromb. Res.
– volume: 16
  start-page: 396
  year: 2006
  end-page: 400
  ident: CR172
  article-title: DNase expression allows the pathogen group A to escape killing in neutrophil extracellular traps
  publication-title: Curr. Biol.
– volume: 26
  start-page: 2157
  year: 2020
  end-page: 2161
  ident: CR29
  article-title: Clinicopathologic and immunohistochemical findings from autopsy of patient with COVID-19, Japan
  publication-title: Emerg. Infect. Dis.
– volume: 9
  start-page: 1898
  year: 2018
  ident: CR118
  article-title: Meta-analysis of preclinical studies of fibrinolytic therapy for acute lung injury
  publication-title: Front. Immunol.
– volume: 107
  start-page: 15880
  year: 2010
  end-page: 15885
  ident: CR141
  article-title: Extracellular DNA traps promote thrombosis
  publication-title: Proc. Natl Acad. Sci. USA
– volume: 382
  year: 2020
  ident: CR145
  article-title: Coagulopathy and antiphospholipid antibodies in patients with COVID-19
  publication-title: N. Engl. J. Med.
– volume: 288
  start-page: 192
  year: 2020
  end-page: 206
  ident: CR1
  article-title: COVID-19 diagnosis and management: a comprehensive review
  publication-title: J. Intern. Med.
– volume: 203
  start-page: 631
  year: 2004
  end-page: 637
  ident: CR59
  article-title: Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
  publication-title: J. Pathol.
– volume: 9
  start-page: 13276
  year: 2018
  end-page: 13286
  ident: CR135
  article-title: Neutrophil extracellular traps promote lipopolysaccharide-induced airway inflammation and mucus hypersecretion in mice
  publication-title: Oncotarget
– volume: 18
  start-page: 1747
  year: 2020
  end-page: 1751
  ident: CR4
  article-title: The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome
  publication-title: J. Thromb. Haemost.
– volume: 113
  start-page: 708
  year: 2015
  end-page: 718
  ident: CR64
  article-title: VWF excess and ADAMTS13 deficiency: a unifying pathomechanism linking inflammation to thrombosis in DIC, malaria, and TTP
  publication-title: Thromb. Haemost.
– volume: 130
  start-page: 6151
  year: 2020
  end-page: 6157
  ident: CR86
  article-title: Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis
  publication-title: J. Clin. Invest.
– volume: 39
  start-page: 517
  year: 2017
  end-page: 528
  ident: CR96
  article-title: Cytokine storm and sepsis disease pathogenesis
  publication-title: Semin. Immunopathol.
– volume: 8
  year: 2012
  ident: CR175
  article-title: Two distinct coagulase-dependent barriers protect from neutrophils in a three dimensional in vitro infection model
  publication-title: PLoS Pathog.
– volume: 395
  start-page: 1417
  year: 2020
  end-page: 1418
  ident: CR47
  article-title: Endothelial cell infection and endotheliitis in COVID-19
  publication-title: Lancet
– volume: 222
  start-page: 1789
  year: 2020
  end-page: 1793
  ident: CR65
  article-title: Circulating endothelial cells as a marker of endothelial injury in severe COVID-19
  publication-title: J. Infect. Dis.
– volume: 37
  start-page: 100756
  year: 2020
  ident: CR138
  article-title: Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection
  publication-title: N. Microbes N. Infect.
– volume: 133
  start-page: 4
  year: 2008
  end-page: 12
  ident: CR57
  article-title: Pathogenetic mechanisms of severe acute respiratory syndrome
  publication-title: Virus Res.
– volume: 67
  start-page: 2990
  year: 2015
  end-page: 3003
  ident: CR92
  article-title: Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome
  publication-title: Arthritis Rheumatol.
– volume: 18
  start-page: 1738
  year: 2020
  end-page: 1742
  ident: CR34
  article-title: Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis
  publication-title: J. Thromb. Haemost.
– volume: 5
  year: 2020
  ident: CR120
  article-title: New (re)purpose for an old drug: purinergic modulation may extinguish the COVID-19 thromboinflammatory firestorm
  publication-title: JCI Insight
– volume: 13
  start-page: 34
  year: 2013
  end-page: 45
  ident: CR10
  article-title: Thrombosis as an intravascular effector of innate immunity
  publication-title: Nat. Rev. Immunol.
– volume: 24
  year: 2020
  ident: CR76
  article-title: COVID-19 pneumonia: ARDS or not?
  publication-title: Crit. Care
– volume: 7
  year: 2012
  ident: CR161
  article-title: Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis
  publication-title: PLoS ONE
– volume: 87
  start-page: 2337
  year: 1996
  end-page: 2344
  ident: CR114
  article-title: Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase
  publication-title: Blood
– volume: 6
  start-page: 417
  year: 2014
  end-page: 425
  ident: CR90
  article-title: Myeloperoxidase directs properdin-mediated complement activation
  publication-title: J. Innate Immun.
– volume: 4
  start-page: e00271
  year: 2013
  end-page: 13
  ident: CR44
  article-title: Mechanisms of severe acute respiratory syndrome coronavirus-induced acute lung injury
  publication-title: mBio
– volume: 1
  start-page: e290
  year: 2020
  end-page: e299
  ident: CR9
  article-title: Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study
  publication-title: Lancet Microbe
– volume: 5
  year: 2020
  ident: CR85
  article-title: Neutrophil extracellular traps in COVID-19
  publication-title: JCI Insight
– volume: 133
  start-page: 4
  year: 2008
  ident: 536_CR57
  publication-title: Virus Res.
  doi: 10.1016/j.virusres.2007.01.022
– volume: 9
  start-page: 1795
  year: 2011
  ident: 536_CR164
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/j.1538-7836.2011.04422.x
– volume: 118
  start-page: 1110
  year: 2008
  ident: 536_CR168
  publication-title: J. Clin. Invest.
– volume: 5
  year: 2020
  ident: 536_CR144
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.140711
– volume: 324
  start-page: 782
  year: 2020
  ident: 536_CR11
  publication-title: JAMA
  doi: 10.1001/jama.2020.12839
– volume: 10
  start-page: 1205
  year: 2020
  ident: 536_CR125
  publication-title: Acta Pharm. Sin. B
  doi: 10.1016/j.apsb.2020.04.008
– volume: 215
  start-page: 108450
  year: 2020
  ident: 536_CR149
  publication-title: Clin. Immunol.
  doi: 10.1016/j.clim.2020.108450
– volume: 383
  start-page: 2451
  year: 2020
  ident: 536_CR12
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMcp2009575
– volume: 20
  start-page: 389
  year: 2020
  ident: 536_CR55
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-020-0343-0
– volume: 24
  start-page: 4040
  year: 2020
  ident: 536_CR147
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 30
  start-page: 1914
  year: 2020
  ident: 536_CR39
  publication-title: Nutr. Metab. Cardiovasc. Dis.
  doi: 10.1016/j.numecd.2020.07.040
– volume: 23
  start-page: 168
  year: 2003
  ident: 536_CR69
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.0000051384.43104.FC
– volume: 133
  start-page: 906
  year: 2019
  ident: 536_CR158
  publication-title: Blood
  doi: 10.1182/blood-2018-11-882993
– volume: 3
  year: 2018
  ident: 536_CR136
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.98178
– volume: 4
  start-page: 744
  year: 2020
  ident: 536_CR107
  publication-title: Res. Pract. Thromb. Haemost.
  doi: 10.1002/rth2.12400
– volume: 57
  start-page: 102833
  year: 2020
  ident: 536_CR28
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2020.102833
– volume: 119
  start-page: 6335
  year: 2012
  ident: 536_CR137
  publication-title: Blood
  doi: 10.1182/blood-2012-01-405183
– volume: 395
  start-page: 1033
  year: 2020
  ident: 536_CR19
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30628-0
– volume: 584
  start-page: 425
  year: 2020
  ident: 536_CR13
  publication-title: Nature
  doi: 10.1038/s41586-020-2488-1
– volume: 46
  start-page: 1099
  year: 2020
  ident: 536_CR78
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-020-06033-2
– volume: 20
  start-page: 343
  year: 2020
  ident: 536_CR146
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-020-0320-7
– volume: 288
  start-page: 192
  year: 2020
  ident: 536_CR1
  publication-title: J. Intern. Med.
  doi: 10.1111/joim.13091
– volume: 581
  start-page: 465
  year: 2020
  ident: 536_CR98
  publication-title: Nature
  doi: 10.1038/s41586-020-2196-x
– volume: 3
  start-page: e224
  year: 2021
  ident: 536_CR151
  publication-title: Lancet Rheumatol.
  doi: 10.1016/S2665-9913(20)30420-3
– volume: 16
  start-page: 19
  year: 2019
  ident: 536_CR91
  publication-title: Cell Mol. Immunol.
  doi: 10.1038/s41423-018-0024-0
– volume: 39
  start-page: 517
  year: 2017
  ident: 536_CR96
  publication-title: Semin. Immunopathol.
  doi: 10.1007/s00281-017-0639-8
– volume: 37
  start-page: 100756
  year: 2020
  ident: 536_CR138
  publication-title: N. Microbes N. Infect.
  doi: 10.1016/j.nmni.2020.100756
– volume: 173
  start-page: 268
  year: 2020
  ident: 536_CR7
  publication-title: Ann. Intern. Med.
  doi: 10.7326/M20-2003
– volume: 395
  start-page: 1417
  year: 2020
  ident: 536_CR47
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30937-5
– volume: 12
  start-page: eabd3876
  year: 2020
  ident: 536_CR94
  publication-title: Sci. Transl Med.
  doi: 10.1126/scitranslmed.abd3876
– volume: 16
  start-page: 396
  year: 2006
  ident: 536_CR172
  publication-title: Curr. Biol.
  doi: 10.1016/j.cub.2005.12.039
– volume: 26
  start-page: 2157
  year: 2020
  ident: 536_CR29
  publication-title: Emerg. Infect. Dis.
  doi: 10.3201/eid2609.201353
– volume: 26
  start-page: 1017
  year: 2020
  ident: 536_CR5
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0968-3
– volume: 4
  start-page: e00271
  year: 2013
  ident: 536_CR44
  publication-title: mBio
  doi: 10.1128/mBio.00271-13
– volume: 16
  start-page: 887
  year: 2010
  ident: 536_CR159
  publication-title: Nat. Med.
  doi: 10.1038/nm.2184
– volume: 113
  start-page: 708
  year: 2015
  ident: 536_CR64
  publication-title: Thromb. Haemost.
  doi: 10.1160/TH14-09-0731
– volume: 182
  start-page: 7997
  year: 2009
  ident: 536_CR170
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.0802884
– volume: 76
  start-page: 122
  year: 2020
  ident: 536_CR105
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2020.05.001
– volume: 9
  start-page: 364
  year: 2009
  ident: 536_CR157
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri2532
– volume: 217
  year: 2020
  ident: 536_CR88
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20201012
– volume: 1
  start-page: e290
  year: 2020
  ident: 536_CR9
  publication-title: Lancet Microbe
  doi: 10.1016/S2666-5247(20)30144-0
– volume: 45
  start-page: 100731
  year: 2021
  ident: 536_CR40
  publication-title: Blood Rev.
  doi: 10.1016/j.blre.2020.100731
– volume: 201
  start-page: 1299
  year: 2020
  ident: 536_CR77
  publication-title: Am. J. Respir. Crit. Care Med.
  doi: 10.1164/rccm.202003-0817LE
– volume: 18
  start-page: 1094
  year: 2020
  ident: 536_CR152
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/jth.14817
– volume: 69
  start-page: 1181
  year: 2020
  ident: 536_CR38
  publication-title: Inflamm. Res.
  doi: 10.1007/s00011-020-01401-6
– volume: 127
  start-page: 571
  year: 2020
  ident: 536_CR3
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.120.317447
– volume: 76
  start-page: 369
  year: 2020
  ident: 536_CR110
  publication-title: J. Cardiovasc. Pharmacol.
  doi: 10.1097/FJC.0000000000000893
– volume: 18
  start-page: 844
  year: 2020
  ident: 536_CR33
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/jth.14768
– volume: 18
  start-page: 1548
  year: 2020
  ident: 536_CR43
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/jth.14872
– volume: 20
  start-page: 363
  year: 2020
  ident: 536_CR32
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-020-0311-8
– volume: 6
  start-page: 222ra217
  year: 2014
  ident: 536_CR113
  publication-title: Sci. Transl Med.
  doi: 10.1126/scitranslmed.3006804
– volume: 220
  start-page: 108598
  year: 2020
  ident: 536_CR150
  publication-title: Clin. Immunol.
  doi: 10.1016/j.clim.2020.108598
– volume: 8
  start-page: 1233
  year: 2020
  ident: 536_CR21
  publication-title: Lancet Respir. Med.
  doi: 10.1016/S2213-2600(20)30404-5
– volume: 73
  start-page: 807
  year: 2020
  ident: 536_CR41
  publication-title: J. Hepatol.
  doi: 10.1016/j.jhep.2020.05.002
– volume: 32
  start-page: 1695
  year: 2004
  ident: 536_CR131
  publication-title: Crit. Care Med.
  doi: 10.1097/01.CCM.0000133332.48386.85
– volume: 177
  start-page: 4794
  year: 2006
  ident: 536_CR182
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.177.7.4794
– volume: 20
  start-page: 62
  year: 2018
  ident: 536_CR93
  publication-title: Curr. Rheumatol. Rep.
  doi: 10.1007/s11926-018-0773-x
– volume: 8
  start-page: 420
  year: 2020
  ident: 536_CR54
  publication-title: Lancet Respir. Med.
  doi: 10.1016/S2213-2600(20)30076-X
– volume: 7
  start-page: e362
  year: 2020
  ident: 536_CR104
  publication-title: Lancet Haematol.
  doi: 10.1016/S2352-3026(20)30109-5
– volume: 193
  start-page: 170
  year: 2020
  ident: 536_CR63
  publication-title: Thromb. Res.
  doi: 10.1016/j.thromres.2020.07.034
– volume: 129
  start-page: 104444
  year: 2020
  ident: 536_CR25
  publication-title: J. Clin. Virol.
  doi: 10.1016/j.jcv.2020.104444
– volume: 10
  start-page: 191
  year: 2021
  ident: 536_CR45
  publication-title: J. Clin. Med.
  doi: 10.3390/jcm10020191
– volume: 109
  start-page: 4803
  year: 2007
  ident: 536_CR169
  publication-title: Blood
  doi: 10.1182/blood-2006-12-062695
– volume: 34
  start-page: 1805
  year: 2020
  ident: 536_CR155
  publication-title: Leukemia
  doi: 10.1038/s41375-020-0891-0
– volume: 11
  start-page: 1625
  year: 2020
  ident: 536_CR2
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2020.01625
– volume: 222
  start-page: 1789
  year: 2020
  ident: 536_CR65
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiaa528
– volume: 149
  start-page: 38
  year: 2017
  ident: 536_CR60
  publication-title: Thromb. Res.
  doi: 10.1016/j.thromres.2016.11.007
– volume: 13
  start-page: 120
  year: 2020
  ident: 536_CR101
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-020-00954-7
– volume: 11
  start-page: 598308
  year: 2020
  ident: 536_CR128
  publication-title: Front. Pharmacol.
  doi: 10.3389/fphar.2020.598308
– volume: 6
  year: 2011
  ident: 536_CR134
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0028526
– volume: 323
  start-page: 2518
  year: 2020
  ident: 536_CR48
  publication-title: JAMA
  doi: 10.1001/jama.2020.8907
– volume: 142
  start-page: 1176
  year: 2020
  ident: 536_CR71
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.120.048488
– volume: 10
  start-page: eaan8292
  year: 2018
  ident: 536_CR142
  publication-title: Sci. Transl Med.
  doi: 10.1126/scitranslmed.aan8292
– volume: 383
  start-page: 2255
  year: 2020
  ident: 536_CR18
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMra2026131
– volume: 58
  start-page: 102925
  year: 2020
  ident: 536_CR87
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2020.102925
– volume: 10
  start-page: 621
  year: 2014
  ident: 536_CR132
  publication-title: Ther. Clin. Risk Manag.
– volume: 243
  start-page: 111
  year: 2017
  ident: 536_CR74
  publication-title: J. Pathol.
  doi: 10.1002/path.4935
– volume: 5
  year: 2020
  ident: 536_CR85
  publication-title: JCI Insight
– volume: 6
  start-page: 415
  year: 2008
  ident: 536_CR166
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/j.1538-7836.2007.02865.x
– volume: 98
  start-page: 512
  year: 2007
  ident: 536_CR171
  publication-title: Thromb. Haemost.
  doi: 10.1160/TH07-02-0117
– volume: 87
  start-page: 2337
  year: 1996
  ident: 536_CR114
  publication-title: Blood
  doi: 10.1182/blood.V87.6.2337.bloodjournal8762337
– volume: 2
  start-page: e437
  year: 2020
  ident: 536_CR27
  publication-title: Lancet Rheumatol.
  doi: 10.1016/S2665-9913(20)30121-1
– volume: 18
  start-page: 165
  year: 2017
  ident: 536_CR84
  publication-title: Respir. Res.
  doi: 10.1186/s12931-017-0651-5
– volume: 26
  start-page: 842
  year: 2020
  ident: 536_CR30
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-0901-9
– volume: 77
  start-page: 158
  year: 2020
  ident: 536_CR111
  publication-title: Eur. J. Intern. Med.
  doi: 10.1016/j.ejim.2020.06.006
– volume: 7
  start-page: e575
  year: 2020
  ident: 536_CR35
  publication-title: Lancet Haematol.
  doi: 10.1016/S2352-3026(20)30216-7
– volume: 2
  year: 2014
  ident: 536_CR133
  publication-title: J. Intensive Care
  doi: 10.1186/s40560-014-0067-y
– volume: 10
  start-page: 2204
  year: 2019
  ident: 536_CR167
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2019.02204
– volume: 396
  start-page: 320
  year: 2020
  ident: 536_CR99
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)31305-2
– volume: 7
  year: 2012
  ident: 536_CR161
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0045427
– volume: 26
  start-page: 91
  year: 2020
  ident: 536_CR139
  publication-title: Mol. Med.
  doi: 10.1186/s10020-020-00215-w
– volume: 477
  start-page: 349
  year: 2020
  ident: 536_CR97
  publication-title: Virchows Arch.
  doi: 10.1007/s00428-020-02881-x
– volume: 191
  start-page: 9
  year: 2020
  ident: 536_CR37
  publication-title: Thromb. Res.
  doi: 10.1016/j.thromres.2020.04.024
– volume: 220
  start-page: 1
  year: 2020
  ident: 536_CR52
  publication-title: Transl Res.
  doi: 10.1016/j.trsl.2020.04.007
– volume: 146
  start-page: 137
  year: 2020
  ident: 536_CR156
  publication-title: J. Allergy Clin. Immunol.
  doi: 10.1016/j.jaci.2020.05.019
– volume: 26
  start-page: 1609
  year: 2020
  ident: 536_CR179
  publication-title: Nat. Med.
  doi: 10.1038/s41591-020-1021-2
– volume: 2
  year: 2020
  ident: 536_CR15
  publication-title: Crit. Care Explor.
  doi: 10.1097/CCE.0000000000000178
– volume: 51
  start-page: 226
  year: 2021
  ident: 536_CR108
  publication-title: J. Thromb. Thrombolysis
  doi: 10.1007/s11239-020-02212-6
– year: 2020
  ident: 536_CR66
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2020.11.041
– volume: 166
  start-page: 447
  year: 2012
  ident: 536_CR123
  publication-title: Br. J. Pharmacol.
  doi: 10.1111/j.1476-5381.2012.01847.x
– volume: 45
  start-page: 290
  year: 2018
  ident: 536_CR82
  publication-title: Transfus. Med. Hemother
  doi: 10.1159/000492950
– volume: 48
  start-page: 1358
  year: 2020
  ident: 536_CR36
  publication-title: Crit. Care Med.
  doi: 10.1097/CCM.0000000000004656
– volume: 75
  start-page: 2950
  year: 2020
  ident: 536_CR103
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2020.04.031
– volume: 18
  start-page: 1738
  year: 2020
  ident: 536_CR34
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/jth.14850
– volume: 181
  start-page: 1036
  year: 2020
  ident: 536_CR22
  publication-title: Cell
  doi: 10.1016/j.cell.2020.04.026
– volume: 203
  start-page: 631
  year: 2004
  ident: 536_CR59
  publication-title: J. Pathol.
  doi: 10.1002/path.1570
– volume: 76
  start-page: 1815
  year: 2020
  ident: 536_CR154
  publication-title: J. Am. Coll. Cardiol.
  doi: 10.1016/j.jacc.2020.08.041
– volume: 218
  year: 2021
  ident: 536_CR24
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20201707
– volume: 130
  start-page: 2152
  year: 2020
  ident: 536_CR176
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI136094
– volume: 178
  start-page: 579
  year: 1993
  ident: 536_CR180
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.178.2.579
– volume: 324
  start-page: 1565
  year: 2020
  ident: 536_CR20
  publication-title: JAMA
  doi: 10.1001/jama.2020.17052
– volume: 39
  start-page: 529
  year: 2017
  ident: 536_CR95
  publication-title: Semin. Immunopathol.
  doi: 10.1007/s00281-017-0629-x
– volume: 21
  start-page: 3625
  year: 2020
  ident: 536_CR126
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21103625
– volume: 6
  start-page: 417
  year: 2014
  ident: 536_CR90
  publication-title: J. Innate Immun.
  doi: 10.1159/000356980
– volume: 70
  start-page: 7
  year: 2021
  ident: 536_CR23
  publication-title: Inflamm. Res.
  doi: 10.1007/s00011-020-01413-2
– volume: 7
  start-page: eabe4724
  year: 2020
  ident: 536_CR127
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.abe4724
– volume: 28
  start-page: 184
  year: 2007
  ident: 536_CR178
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2007.02.006
– volume: 67
  start-page: 2990
  year: 2015
  ident: 536_CR92
  publication-title: Arthritis Rheumatol.
  doi: 10.1002/art.39247
– volume: 3
  year: 2018
  ident: 536_CR140
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.99445
– volume: 50
  start-page: 298
  year: 2020
  ident: 536_CR153
  publication-title: J. Thromb. Thrombolysis
  doi: 10.1007/s11239-020-02162-z
– volume: 13
  start-page: 34
  year: 2013
  ident: 536_CR10
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/nri3345
– volume: 22
  start-page: 95
  year: 2020
  ident: 536_CR79
  publication-title: Crit. Care Resusc.
– volume: 10
  year: 2019
  ident: 536_CR124
  publication-title: Nat. Commun.
– volume: 24
  year: 2020
  ident: 536_CR130
  publication-title: Crit. Care
– volume: 8
  start-page: 681
  year: 2020
  ident: 536_CR6
  publication-title: Lancet Respir. Med.
  doi: 10.1016/S2213-2600(20)30243-5
– volume: 84
  start-page: 1680
  year: 2012
  ident: 536_CR56
  publication-title: J. Med. Virol.
  doi: 10.1002/jmv.23354
– volume: 17
  start-page: 46
  year: 2021
  ident: 536_CR68
  publication-title: Nat. Rev. Nephrol.
  doi: 10.1038/s41581-020-00357-4
– volume: 9
  start-page: 1898
  year: 2018
  ident: 536_CR118
  publication-title: Front. Immunol.
  doi: 10.3389/fimmu.2018.01898
– volume: 18
  start-page: 194
  year: 2021
  ident: 536_CR75
  publication-title: Nat. Rev. Cardiol.
  doi: 10.1038/s41569-020-00469-1
– volume: 15
  start-page: 700
  year: 2020
  ident: 536_CR46
  publication-title: J. Thorac. Oncol.
  doi: 10.1016/j.jtho.2020.02.010
– volume: 19
  start-page: 2029
  year: 1999
  ident: 536_CR102
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/01.ATV.19.9.2029
– volume: 77
  start-page: 394
  year: 1997
  ident: 536_CR181
  publication-title: Thromb. Haemost.
  doi: 10.1055/s-0038-1655974
– volume: 58
  start-page: 1021
  year: 2020
  ident: 536_CR26
  publication-title: Clin. Chem. Lab. Med.
  doi: 10.1515/cclm-2020-0369
– volume: 79
  start-page: 11062
  year: 2005
  ident: 536_CR121
  publication-title: J. Virol.
  doi: 10.1128/JVI.79.17.11062-11070.2005
– volume: 382
  year: 2020
  ident: 536_CR145
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMc2007575
– volume: 217
  year: 2020
  ident: 536_CR89
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20201129
– volume: 16
  start-page: 401
  year: 2006
  ident: 536_CR173
  publication-title: Curr. Biol.
  doi: 10.1016/j.cub.2006.01.056
– volume: 8
  year: 2012
  ident: 536_CR175
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1002434
– volume: 172
  start-page: 629
  year: 2020
  ident: 536_CR53
  publication-title: Ann. Intern. Med.
  doi: 10.7326/M20-0533
– volume: 126
  start-page: 3783
  year: 2016
  ident: 536_CR143
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI83873
– volume: 7
  start-page: 678
  year: 2016
  ident: 536_CR81
  publication-title: Front. Immunol.
– volume: 28
  start-page: 100590
  year: 2020
  ident: 536_CR148
  publication-title: EClinicalMedicine
  doi: 10.1016/j.eclinm.2020.100590
– volume: 196
  start-page: 395
  year: 2020
  ident: 536_CR109
  publication-title: Thromb. Res.
  doi: 10.1016/j.thromres.2020.09.024
– volume: 118
  start-page: 6
  year: 2018
  ident: 536_CR162
  publication-title: Thromb. Haemost.
  doi: 10.1160/TH17-09-0630
– volume: 42
  start-page: 252
  year: 2016
  ident: 536_CR72
  publication-title: Semin. Thromb. Hemost.
  doi: 10.1055/s-0035-1570080
– volume: 39
  start-page: 405
  year: 2020
  ident: 536_CR14
  publication-title: J. Heart Lung Transpl.
  doi: 10.1016/j.healun.2020.03.012
– volume: 136
  start-page: 1317
  year: 2020
  ident: 536_CR100
  publication-title: Blood
  doi: 10.1182/blood.2020007214
– volume: 361
  start-page: 1773
  year: 2003
  ident: 536_CR49
  publication-title: Lancet
  doi: 10.1016/S0140-6736(03)13413-7
– volume: 190
  start-page: 62
  year: 2020
  ident: 536_CR62
  publication-title: Thromb. Res.
  doi: 10.1016/j.thromres.2020.04.014
– volume: 18
  start-page: 1752
  year: 2020
  ident: 536_CR119
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/jth.14828
– volume: 18
  start-page: 1521
  year: 2020
  ident: 536_CR115
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/jth.14858
– volume: 123
  start-page: 2768
  year: 2014
  ident: 536_CR163
  publication-title: Blood
  doi: 10.1182/blood-2013-10-463646
– volume: 130
  start-page: 6151
  year: 2020
  ident: 536_CR86
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI141374
– volume: 395
  start-page: 497
  year: 2020
  ident: 536_CR16
  publication-title: Lancet
  doi: 10.1016/S0140-6736(20)30183-5
– volume: 21
  start-page: 49
  year: 2021
  ident: 536_CR31
  publication-title: Nat. Rev. Immunol.
  doi: 10.1038/s41577-020-00470-2
– volume: 19
  start-page: 102537
  year: 2020
  ident: 536_CR50
  publication-title: Autoimmun. Rev.
  doi: 10.1016/j.autrev.2020.102537
– volume: 179
  start-page: 1160
  year: 2019
  ident: 536_CR122
  publication-title: Cell
  doi: 10.1016/j.cell.2019.10.027
– volume: 209
  start-page: 819
  year: 2012
  ident: 536_CR160
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20112322
– volume: 18
  start-page: 1747
  year: 2020
  ident: 536_CR4
  publication-title: J. Thromb. Haemost.
  doi: 10.1111/jth.14854
– volume: 107
  start-page: 15880
  year: 2010
  ident: 536_CR141
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.1005743107
– volume: 46
  start-page: 1089
  year: 2020
  ident: 536_CR61
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-020-06062-x
– volume: 9
  year: 2018
  ident: 536_CR177
  publication-title: mBio
  doi: 10.1128/mBio.01753-18
– volume: 77
  start-page: 18
  year: 2020
  ident: 536_CR42
  publication-title: Eur. J. Intern. Med.
  doi: 10.1016/j.ejim.2020.05.035
– volume: 16
  start-page: 1323
  year: 2016
  ident: 536_CR117
  publication-title: Expert. Opin. Biol. Ther.
  doi: 10.1080/14712598.2016.1227779
– volume: 9
  start-page: 13276
  year: 2018
  ident: 536_CR135
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.24022
– volume: 50
  start-page: 72
  year: 2020
  ident: 536_CR106
  publication-title: J. Thromb. Thrombolysis
  doi: 10.1007/s11239-020-02138-z
– volume: 6
  year: 2010
  ident: 536_CR174
  publication-title: PLoS Pathog.
  doi: 10.1371/journal.ppat.1001036
– volume: 236
  start-page: 1638
  year: 2021
  ident: 536_CR17
  publication-title: J. Cell Physiol.
  doi: 10.1002/jcp.30008
– volume: 40
  start-page: 922
  year: 2019
  ident: 536_CR165
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2019.08.004
– volume: 200
  start-page: 282
  year: 2003
  ident: 536_CR58
  publication-title: J. Pathol.
  doi: 10.1002/path.1440
– volume: 5
  year: 2020
  ident: 536_CR120
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.140971
– volume: 116
  start-page: 1932
  year: 2020
  ident: 536_CR51
  publication-title: Cardiovasc. Res.
  doi: 10.1093/cvr/cvaa093
– volume: 20
  start-page: 1135
  year: 2020
  ident: 536_CR8
  publication-title: Lancet Infect. Dis.
  doi: 10.1016/S1473-3099(20)30434-5
– volume: 130
  start-page: 581
  year: 2019
  ident: 536_CR83
  publication-title: Anesthesiology
  doi: 10.1097/ALN.0000000000002619
– volume: 217
  year: 2020
  ident: 536_CR129
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.20200652
– volume: 136
  start-page: 1330
  year: 2020
  ident: 536_CR70
  publication-title: Blood
  doi: 10.1182/blood.2020007252
– volume: 60
  start-page: 6532
  year: 2016
  ident: 536_CR116
  publication-title: Antimicrob. Agents Chemother.
  doi: 10.1128/AAC.01043-16
– volume: 289
  start-page: 411
  year: 2021
  ident: 536_CR112
  publication-title: J. Intern. Med.
  doi: 10.1111/joim.13205
– volume: 127
  start-page: 1404
  year: 2020
  ident: 536_CR73
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.120.317703
– volume: 136
  start-page: 1169
  year: 2020
  ident: 536_CR80
  publication-title: Blood
  doi: 10.1182/blood.2020007008
– volume: 323
  start-page: 2329
  year: 2020
  ident: 536_CR67
  publication-title: JAMA
  doi: 10.1001/jama.2020.6825
– volume: 24
  year: 2020
  ident: 536_CR76
  publication-title: Crit. Care
  doi: 10.1186/s13054-020-02880-z
– reference: 34677789 - Intern Emerg Med. 2022 Mar;17(2):593-596
SSID ssj0016174
Score 2.7379177
SecondaryResourceType review_article
Snippet Coronavirus disease 2019 (COVID-19) is a clinical syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 319
SubjectTerms 631/250/127
631/250/2499
631/250/2500
631/250/255/2514
631/250/262
Biomedical and Life Sciences
Biomedicine
Blood clot
Blood Coagulation - immunology
Blood Platelets - immunology
Coronaviruses
COVID-19
COVID-19 - immunology
COVID-19 - pathology
Critical Illness - therapy
Cytokine Release Syndrome - immunology
Cytokine Release Syndrome - pathology
Development and progression
Drug development
Endothelium
Endothelium, Vascular - pathology
Fibrinolytic Agents - therapeutic use
Health aspects
Humans
Immune response
Immune system
Immunity, Innate - immunology
Immunology
Immunosuppressive agents
Infections
Leukocytes (neutrophilic)
Lung - blood supply
Lung - pathology
Lung - virology
Monocytes
Monocytes - immunology
Neutrophils - immunology
Patients
Perspective
Respiratory distress syndrome
SARS-CoV-2 - immunology
SARS-CoV-2 - pathogenicity
Severe acute respiratory syndrome coronavirus 2
Thrombosis
Venous Thrombosis - immunology
Venous Thrombosis - pathology
Venous Thrombosis - prevention & control
Title Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
URI https://link.springer.com/article/10.1038/s41577-021-00536-9
https://www.ncbi.nlm.nih.gov/pubmed/33824483
https://www.proquest.com/docview/2521813236
https://www.proquest.com/docview/2509605689
https://pubmed.ncbi.nlm.nih.gov/PMC8023349
Volume 21
WOSCitedRecordID wos000637460400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 1474-1741
  dateEnd: 20241213
  omitProxy: false
  ssIdentifier: ssj0016174
  issn: 1474-1733
  databaseCode: 7RV
  dateStart: 20011001
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYBogXPsZXYRSDkHgAa4vt2s4TGqUTe6BUhU19s2I7gUhrMuYWaf89vsTtSCX2Qh-sSj5Xud75zs7d_Q6hN7QwlnFhiBoYSXhhRPhGEyJkZvLCKpo52zSbkOOxms3SSXzh5mNa5comNoba1Rbeke_TATgjRpn4cP6LQNcoiK7GFhpbaAeQyoKe73wcjSfTdRxBtDjMCZecJJKxWDZzwNS-D65LSgIpCqCJgqQd17RpoP_yUJvZkxsh1MYzHd37X57uo7vxTIoPWyV6gG7k1S661XapvNxFt7_E-PtDdDKqHJRsnQWtxe7Sg1cEyeKscriEUpMa-i7MTe1LjzOPg4nA0PS4DnpaWjzPodC49HOPywoPv54efyJJ-gidHI2-Dz-T2JiBWCHpgjSggsbwcDcpjEuzA5sqQ2VGXZLkVBhLTcEED6wVaTDshVIFLzIXrnZc5C7l7DHaruoqf4owz5wRTLqEcThbDJSlljtaOB4-yqU9lKxkom1ELYfmGWe6iZ4zpVs56iBH3chRhzXv1mvOW8yOa6lfgqh1W3e63vD6UAgIU4frYg-9bigALqOCfJwf2dJ7ffxt2iF6G4mKOjygzWJ5Q2ATELY6lHsdyrCfbXd6pSw62hOvrzSlh16tp2El5MhVeb0EGriODoQKLD1pVXTNPmMqnOMU6yHZUd41AaCMd2eq8meDNg4IgYyH33y_UvOrx_r3v_rsei6eozu02XmQObqHthcXy_wFuml_L0p_0UdbcnoK40w2owqjGib9uLv7kKA7-QNJVlAb
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Jb9QwFLZKWS8sZRso1CAQB4g6sT2Oc0Co6qKOulBBi3ozsZ1ApE5S6hnQ_Cl-I-9lmZKR6K0Hcork5yQv-d7i-C2EvGKZsVxIE6iBiQKRGQlnLAxklJg0s4olzlbNJqL9fXV8HB8skN9tLgyGVbY6sVLUrrT4j3yVDdAYccblh9MfAXaNwt3VtoVGDYuddPoLlmz-_XADvu9rxrY2D9e3g6arQGBlxMZBVRHPGAGOdWZcnPRtrAyLEubCMGXSWGYyLgXcK4tBK2VKZSJLHKxLhExdLDhc9wq5Cm4E61ehggezXQtZV30ORSSCMOK8SdLpc7XqwVBGUYABEYh7GcQdQzhvDv6yh_OxmnMbtpUd3Lrzv73Bu-R243HTtVpE7pGFtFgi1-senNMlcmOviS64T442C4cJaScgk9RNPdp8xC1NCkdzTKQpsavEyJQ-9zTxFBQgxZbOJUhhbukoxTTq3I88zQu6_vHLcCMI4wfk6FLYe0gWi7JIHxMqEmckj1zIBXpOA2WZFY5lTsChXNwjYYsBbZua7Nga5ERXsQFc6Ro3GnCjK9xomPN2Nue0rkhyIfUKQkvXWbUzdabXpMRNeFgM98jLigKLgRQYbfQtmXivh58_dYjeNERZCQ9okyZ5A9jE-mEdyuUOJWgr2x1uwakbben1OTJ75MVsGGdiBGCRlhOkwcX2QCpg6VEtEjP2OVfgpSreI1FHWGYEWEO9O1Lk36ta6lj_kAu45rtWrM4f699v9cnFXKyQm9uHe7t6d7i_85TcYpXUY4zsMlkcn03SZ-Sa_TnO_dnzSn9Q8vWyxe0PEVioMA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLbGgIkXLuNWGMwgEA8QtbFd23lAaFpXUQ3KBAztzcR2ApHWZMwtqH-NX4dPbiOV2NseyFMkHyc5yXcujs8FoWck1YYyrgM51CJgqeb-jIQBF7FOUiNJbE3ZbEJMp_LoKDpYQ7-bXBgIq2x0YqmobWHgH3mfDMEYUUJ5P63DIg5G4zcnPwLoIAU7rU07jQoi-8nyl1--udeTkf_WzwkZ733efRvUHQYCwwWZB2V1PK2Zd7JTbaN4YCKpiYiJDcOEcG2ITiln_r5p5DVUKmXK0tj6NQrjiY0Y9de9hC4LxgekDBs8aHcweFUBOmSCBaGgtE7YGVDZd95oChFAcATIAA-ijlFcNQ1_2cbVuM2VzdvSJo5v_M9v8ya6XnvieKcSnVtoLck30dWqN-dyE228r6MObqPDvdxCotqxl1Vslw58AcAzjnOLM0iwKaDbxEwXLnM4dtgrRgytngsvnZnBswTSqzM3czjL8e6HL5NREEZ30OGFsHcXredFntxHmMVWcypsSBl4VENpiGGWpJb5Q9qoh8IGD8rUtdqhZcixKmMGqFQVhpTHkCoxpPycl-2ck6pSybnU2wAzVWXbtmpO7XAOm_N-kdxDT0sKKBKSA0C-xQvn1OTTxw7Ri5ooLfwDmrhO6vBsQl2xDuVWh9JrMdMdboCqai3q1BlKe-hJOwwzITIwT4oF0MAifMilZ-leJR4t-5RK771K2kOiIzgtAdRW747k2feyxjrURaTMX_NVI2Jnj_Xvt_rgfC620YaXMvVuMt1_iK6RUgFA6OwWWp-fLpJH6Ir5Oc_c6eNSlWD09aKl7Q9cLrD2
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Endothelial+dysfunction+and+immunothrombosis+as+key+pathogenic+mechanisms+in+COVID-19&rft.jtitle=Nature+reviews.+Immunology&rft.au=Bonaventura%2C+Aldo&rft.au=Vecchi%C3%A9%2C+Alessandra&rft.au=Dagna%2C+Lorenzo&rft.au=Martinod%2C+Kimberly&rft.date=2021-05-01&rft.pub=Nature+Publishing+Group&rft.issn=1474-1733&rft.volume=21&rft.issue=5&rft.spage=319&rft_id=info:doi/10.1038%2Fs41577-021-00536-9&rft.externalDocID=A660672148
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1474-1733&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1474-1733&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1474-1733&client=summon